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EMPAGRAN, THE FTAIA AND 
EXTRATERRITORIAL EFFECTS:  
GUIDANCE TO COURTS FACING 
QUESTIONS OF ANTITRUST  
JURISDICTION STILL LACKING 
“As a moth is drawn to the light, so is a litigant drawn to the United 
States.”—Lord Denning1 
“In the globalization system, where you are doesn’t matter much any-
more.”—Thomas Friedman2 
I. INTRODUCTION 
he United States has the most developed and aggressive antitrust 
regime in the world, so it is not surprising that parties injured by 
worldwide price-fixing conspiracies would prefer to litigate their claims 
here than anywhere else.3 Our case law is filled with examples of domes-
tic plaintiffs litigating antitrust claims against foreign defendants, and 
foreign plaintiffs litigating antitrust claims against domestic defendants.4 
But recently a new twist has appeared: foreign plaintiffs bringing their 
antitrust claims against foreign defendants, in U.S. courts for injuries that 
took place outside the United States.5 
At issue is the extraterritorial reach of the U.S. antitrust laws. The 
question is this: Can victims injured abroad by a worldwide price-fixing 
conspiracy bring suit in U.S. federal courts under U.S. antitrust law when 
the antitrust conduct also has an effect on domestic business? After three 
different Courts of Appeal answered the question in three different 
                                                                                                             
 1. Smith Kline & French Lab. Ltd. v. Bloch, [1983] 1 W.L.R. 730, 733 (Eng.), 
quoted in Spencer Weber Waller, The United States as Antitrust Courtroom to the World: 
Jurisdiction and Standing Issues in Transnational Litigation, 14 LOY. CONSUMER L. REV. 
523, 523 (2002) [hereinafter Waller, Courtroom]. 
 2. THOMAS L. FRIEDMAN, THE LEXUS AND THE OLIVE TREE 246 (Anchor Books 
2000) (1999). 
 3. Waller, Courtroom, supra note 1, at 532 (explaining that there is a strong incen-
tive for plaintiffs to bring price-fixing claims under the Sherman Act in the United States, 
rather than elsewhere, due in large part to the treble-damages provision of the Clayton 
Act and the United States’ more liberal discovery procedures, as well as class actions, 
contingent fees, punitive damages and jury trials.) 
 4. See Joseph P. Griffin, Extraterritoriality in U.S. and EU Antitrust Enforcement, 
67 ANTITRUST L.J. 159 (1999). 
 5. 1 VED P. NANDA & DAVID K. PANSIUS, LITIGATION OF INT’L DISPUTES IN U.S. 
COURTS § 8:13 (2005) [hereinafter 1 NANDA & PANSIUS]. 
T 
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ways,6 the U.S. Supreme Court granted certiorari to settle the issue, and 
held that U.S. courts do not have jurisdiction under U.S. antitrust laws to 
try a case in which foreign buyers allege they have been injured by the 
price-fixing actions of foreign sellers—but only where the foreign injury 
is independent of any effect on U.S. commerce.7 The decision left open 
the question of whether foreign plaintiffs could bring actions in the 
United States if the foreign injury is dependent on the effect of the injury 
on U.S. business8 and, further, what is the standard for dependence?9 
The case, F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I),10 
was the penultimate action in a years-long string of litigation that was set 
in motion11 in 1997 when the U.S. government began to prosecute ten 
companies and their corporate executives for conspiring to fix the prices 
and allocate sales of bulk vitamins.12 
That prosecution, known as the Vitamins Case, resulted in the largest 
fines in U.S. history and spawned a host of civil class action lawsuits in 
the United States that led to record settlements.13 Hoffman-La Roche, a 
Swiss manufacturer, agreed to pay $500 million, and BASF Aktienge-
sellschaft, a German manufacturer, paid $225 million.14 More than ten 
corporate officials went to jail.15 Subsequently, three Japanese corpora-
tions, two more German companies, and two U.S. companies pleaded 
                                                                                                             
 6. See generally Den Norske Stats Oljeselskap As v. HeereMac Vof, 241 F.3d 420 
(5th Cir. 2001); Kruman v. Christie’s Int’l PLC, 284 F.3d 384 (2d Cir. 2002); Empagran 
S.A. v. F. Hoffman-La Roche, Ltd., 2001 WL 761360 (D.D.C. 2001). 
 7. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 155, 175 
(2004). 
 8. Id.  
 9. See infra Part V. 
 10. Empagran I, 542 U.S. 155. 
 11. Bernard Persky, Empagran and the International Reach of U.S. Antitrust Laws, 
21 NYSBA ANTITRUST LAW SECTION SYMPOSIUM 21 (2005). 
 12. See Harry First, The Vitamins Case: Cartel Prosecutions and the Coming of In-
ternational Competition Law, 68 ANTITRUST L.J. 711, 712-17 (2001) [hereinafter First, 
Vitamins], for a comprehensive overview of the Vitamins litigation. See also Spencer 
Weber Waller, The Incoherence of Punishment in Antitrust, 78 CHI.-KENT L. REV. 207, 
222 (2003) [hereinafter Waller, Incoherence]. 
 13. First, Vitamins, supra note 12, 712–17. 
 14. Roxanne C. Busey & Patrick J. Kelleher, A Short History of Civil and Criminal 
Antitrust Remedies and Penalties, chart at 1, http://gcd.com/newsevents/publications 
(follow “Publications Archive” hyperlink, choose “Litigation” under dropdown search) 
(last visited Mar. 26, 2006). 
 15. Jane Whittaker & Elliot Thomas, Three Meanings of the Indefinite Article, Three 
Judgments and the Global Reach of U.S. Anti-Trust Laws, 25 BUS. L. REV. 112, 112–14 
(2004) (U.K.). 
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guilty and paid large fines,16 with U.S. criminal fines totaling over $1 
billion.17 
Concurrent with the criminal enforcement, direct purchasers of the vi-
tamins and vitamin premixes18 brought class action suits in federal 
courts,19 settling with six of the companies for $1.05 billion, “the largest 
private antitrust price-fixing settlement in history.”20 Twenty-two states’ 
attorneys general shared an additional $340 million on behalf of the 
states and their citizens.21 
Finally, five non-U.S. vitamin distributors, all of whom had conducted 
their transactions entirely outside the United States, attempted to recover 
damages in a class action in U.S. district court under U.S. antitrust law.22 
These plaintiffs had purchased vitamins abroad from cartel members (or 
their alleged co-conspirators) between January 1, 1988, and February 
1999, and had taken delivery outside the United States.23 This was the 
action that came to be known as Empagran. 
The defendants moved for dismissal, arguing that the court did not 
have power to adjudicate the case under the Foreign Trade Antitrust Im-
provement Act (FTAIA), a statute that limits the extraterritorial reach of 
                                                                                                             
 16. First, Vitamins, supra note 12, at 716–17. 
 17. Waller, Incoherence, supra note 12. 
 18. First, Vitamins, supra note 12, at 718. As First explains, vitamin manufacturers 
blend their products into combinations of vitamins. The components of each blend are 
determined by the use to which the blend will be put (for example, to be added to a type 
of animal feed, or a breakfast cereal supplement). The vitamins manufacturers also sell 
their vitamins “straight” to independent blenders who mix them themselves. The inde-
pendent blenders’ suspicions that collusion was occurring among the vitamins manufac-
turers led to the class action lawsuits. Id. at 712–13. 
 19. Id. at 713. A final judgment in a suit by the government that a person has violated 
the antitrust laws is prima facie evidence against the defendant in a subsequent private 
damage action, under § 5(a) of the Clayton Act, 15 U.S.C. § 16(a) (1914). 
 20. Id. at 718. 
 21. Waller, Incoherence, supra note 12, at 223–24. 
 22. Empagran S.A. v. F. Hoffman-La Roche, Ltd., 2001 WL 761360, at *1 (D.D.C. 
2001). 
 23. Empagran S.A. v. F. Hoffman-La Roche, Ltd., 315 F.3d 338, 342 (D.C. Cir. 
2003). Two domestic plaintiffs, Procter & Gamble Manufacturing Co. and Procter & 
Gamble Co., were initially part of the class but subsequently transferred their claims to 
another case that involved substantially the same claims and the same defendants. Id. at 
343. The five plaintiffs remaining were companies in Ukraine, Australia, Ecuador, and 
Panama, all of whom had suffered their injuries outside the U.S. market. F. Hoffman-La 
Roche Ltd. v. Empagran S.A., The Supreme Court Restricts the Applicability of U.S. Anti-
trust Laws with Regard to Injuries Suffered Abroad Independently from Effects on the 
U.S. Market, Duke Law, http://www.law.duke.edu/publiclaw/supremecourtonline/com 
mentary/fhovemp.html (last visited Mar. 26, 2006) [hereinafter Duke Law]. 
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the Sherman Antitrust Act.24 The district court dismissed the case,25 and 
plaintiffs appealed, arguing that the court had misinterpreted the 
FTAIA.26 
The FTAIA exempts from the reach of the Sherman Act both U.S. ex-
port-only activity and other commercial activities that take place totally 
abroad, unless such activities negatively affect U.S. domestic com-
merce.27 Courts had split over a key phrase in the statute regarding 
whether that activity must be the basis for the plaintiff’s own claim, or 
whether it was merely necessary that someone had a claim.28 
In deciding the issue, the Supreme Court gave short shrift to the se-
mantic inquiry and deterrence arguments that had split the circuits and 
instead looked to principles of international law and comity to define the 
scope of the FTAIA29—a somewhat surprising approach considering that 
the Court had ruled out comity in a leading case only twelve years be-
fore.30 
Key to the Court’s decision was the distinction between dependent and 
independent effects.31 The Court held that when the foreign plaintiff’s 
injury is independent of the effect of defendant’s conduct on U.S. com-
merce, U.S. courts have no jurisdiction.32 Some believe the Court was 
implying it would have had jurisdiction if the foreign plaintiff’s injury 
would not have occurred “but-for” the effect of the conduct on the U.S. 
market.33 Others believe the Court could not have meant that but-for 
linkage would be enough, because such a loose standard would be 
enough to support jurisdiction in virtually every such case.34 In fact, it 
has been said that the Court decided only a hypothetical situation.35 
                                                                                                             
 24. Foreign Trade Antitrust Improvement Act, 15 U.S.C. § 6(a) (1982). See infra Part 
III. 
 25. Empagran, 2001 WL 761360 at *9. 
 26. Empagran, 315 F.3d at 340. 
 27. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 155, 161 
(2004). 
 28. Salil K. Mehra, “A” is for Anachronism: The FTAIA Meets the World Trading 
System, 107 DICK. L. REV. 763, 769 (2003) [hereinafter Mehra, Anachronism]. 
 29. Empagran I, 542 U.S. at 164–73. 
 30. See infra Part IV. 
 31. Empagran I, 542 U.S. at 164. 
 32. Id. at 175. 
 33. Perspectives on Empagran, ANTITRUST SOURCE, Sept. 2004, at 1, 5, http://www. 
abanet.org/antitrust/source/sept04/Sep04Empagran.pdf (presenting remarks by Thomas 
C. Goldstein) [hereinafter Goldstein, Perspectives]. 
 34. John H. Shenefield, Empagran and the International Reach of U.S. Antitrust 
Laws, 21 NYSBA ANTITRUST L. SEC. SYMP. 30 (2005) [hereinafter Shenefield, SYMP-
OSIUM]. 
 35. See infra Part V. 
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With rampant globalization, instantaneous communication, and multi-
nationals building products with components from all over the world and 
selling them far from where they are produced, it may be argued that 
there no longer are independent, national markets. The globalization of 
world trade and instantaneous communication have had a profound effect 
on the world.36 The Internet has certainly complicated the issue further.37 
In today’s globalized economy, businesses are not constrained by politi-
cal or physical borders—“increasingly products have their origins in one 
country, are assembled in a second country, with parts from a third coun-
try, and are sold through fabricators in a fourth country ultimately to 
consumers in a fifth country.”38 When IBM stunned the business world 
in December 2004, by announcing it was in talks to sell its personal 
computer business to a Chinese PC maker, a New York Times article fea-
tured a picture of an IBM laptop with each component identified by its 
source—memory and display screen, South Korea; case, keyboard and 
hard drive, Thailand; wireless card, Malaysia; battery, Asia; graphics 
controller chip, Canada and Taiwan; microprocessor, United States; as-
sembly, Mexico.39 Clearly, these changes in how business operates have 
had an impact on antitrust regulation. While regulation still occurs at the 
national level, increasingly business is done globally.40 
                                                                                                             
 36. See generally FRIEDMAN, supra note 2 (describing the new electronic global econ-
omy). 
 37. Salil K. Mehra, Foreign-Injured Antitrust Plaintiffs in U.S. Courts: Ends and 
Means, 16 LOY. CONSUMER L. REV. 347, 350 (2004) [hereinafter Mehra, Ends and 
Means]. 
 38. John H. Shenefield, Coherence or Confusion: The Future of the Global Antitrust 
Conversation, 49 ANTITRUST BULL. 385, 386 (2004) [hereinafter Shenefield, Coherence]. 
He points out: 
The last 25 years have seen two great trends—globalization and economic lib-
eralization—which together have had a profound and transforming effect on 
most national economies, and concomitantly on efforts to safeguard competi-
tion in those economies by operation of law . . . . 
Even apparently very localized companies cannot remain impervious to the 
combined impact of fluid capital markets, instantaneous international commu-
nication and the economic necessity of producers to buy from and sell into 
global markets. These facts of economic life directly affect regulatory policies: 
trade barriers have been forced down, and restrictions on foreign investments 
have likewise declined. 
Id. 
 39. David Barboza, An Unknown Giant Flexes its Muscles, N.Y. TIMES, Dec. 4, 2004, 
at C1. 
 40. Alexander Layton & Angharad M. Parry, Extraterritorial Jurisdiction—European 
Responses, 26 HOUSTON J. INT’L L. 309, 310 (2004) (“[A]lthough trade is global, there is 
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Amid predictions that the exception would swallow the rule, the Dis-
trict of Columbia Circuit Court, on remand in Empagran, limited its ju-
risdiction to situations in which the domestic effect was the proximate 
cause of the plaintiffs’ injuries.41 But the Supreme Court did not set out 
any standards for determining what the lower courts should consider in 
applying the FTAIA, and since its Empagran decision, cases interpreting 
the FTAIA in other courts have been decided inconsistently.42 The result 
of the Supreme Court’s narrow ruling and lack of clear standard is con-
tinued uncertainty. Prospective plaintiffs still have little guidance on 
whether their claims will ultimately be heard by U.S. courts,43 defendants 
are exposed to risks of unquantifiable later civil claims if they choose to 
settle government suits,44 and foreign governments remain concerned 
about the reach of U.S. laws at a time when many are trying to develop 
their own antitrust regimes.45 
This Note argues that the question of the extraterritorial reach of the 
Sherman Act is still very much open, that the Supreme Court’s decision 
gives limited guidance to the lower courts, and that the answer lies not in 
debating the interdependence of local effects and international injury, but 
in looking beyond the FTAIA for a solution. Part II provides a brief his-
tory of the extraterritorial effect of U.S. antitrust laws; Part III explains 
the split over construction of the FTAIA; Part IV sets out the Supreme 
                                                                                                             
no single global regulator.”); see also Diane P. Wood, The Impossible Dream: Real Inter-
national Antitrust, 1992 U. CHI. LEGAL F. 277, 280 (1992) (arguing that “effective regula-
tion of the competitive process must somehow take place at the same level where the 
business activity itself is pursued, that is, the international level.”). See also David J. Ger-
ber, Prescriptive Authority: Global Markets as a Challenge to National Regulatory Sys-
tems, 26 HOUSTON J. INT’L L. 287, 300 (2004) (“[G]lobal markets represent a source of 
opportunity, but governments can impede competitors’ capacity to take advantage of 
those opportunities. Firms seek to minimize costs of operation, but each state border that 
is crossed may create additional compliance costs. Firms also seek to reduce uncertainty 
and increase planning predictability, but encounters with numerous legal systems reduce 
predictability.”). 
 41. Empagran v. F. Hoffman-La Roche (Empagran II), 417 F.3d 1267, 1271 (D.C. 
Cir. 2005). 
 42. See infra Part V. 
 43. See infra Part VI. 
 44. Defendants, in particular, may be much less likely to agree to settlements when 
facing criminal charges, because their subsequent civil liabilities could be much greater 
(and more difficult to estimate in advance). In fact, the Department of Justice and many 
foreign governments filed amici curiae briefs in the suit because of the potential harm 
such a result could have on antitrust enforcement. See Brief for the United States as 
Amicus Curiae Supporting Petitioners at 20–21, F. Hoffman-La Roche Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). 
 45. See generally Layton & Parry, supra note 40. 
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Court’s Empagran decision; Part V analyzes the aftermath of Empagran 
and recent court decisions construing its rule; Part VI offers a critique of 
the Supreme Court’s decision; and Part VII looks at alternative ap-
proaches for deciding the question of when foreign plaintiffs’ antitrust 
claims should be heard in U.S. courts, including the application of anti-
trust standing and an extension of the doctrine of forum non conveniens. 
II. EXTRATERRITORIALITY 
The extraterritorial application of the U.S. antitrust laws has evolved 
through the years in parallel with the extraordinary growth of transna-
tional business. From the 1920s, when globalization began to develop,46 
through today, when the Internet and instantaneous communication make 
it possible for everyone to be everywhere,47 the principles by which U.S. 
antitrust laws have been applied to foreign entities have shifted.48 
Conflicts were easily resolved when the basis for jurisdiction was pure 
territoriality, since territory has “well-defined and easily identifiable 
boundaries.”49 The territorial approach was exemplified in American Ba-
nana v. United Fruit Co., where American Banana argued that United 
Fruit had seized one of its plantations in Costa Rica in collusion with 
local authorities in violation of the Sherman Act.50 The Supreme Court 
held that the acts were done outside the jurisdiction of the United 
States.51 This approach was the rule on the extraterritorial application of 
U.S. law for the next several decades.52 
Pressures on the doctrine began to mount by the 1920s; by that time the 
international cartel movement was complicating business relationships 
                                                                                                             
 46. Jeremy C. Bates, Comment, Home is Where the Hurt is: Forum Non Conveniens 
and Antitrust, 2000 U. CHI. LEGAL F. 281, 317 (2000) (pointing out that antitrust law 
began its development in an era of rampant globalization resembling today’s world more 
than is recognized). 
 47. Deanell Reece Tacha, The Federal Courts in the 21st Century, 2 CHAP. L. REV. 7, 
25 (1999) (“The Internet knows no national boundaries and renders everyone with net 
access a speaker and a publisher.”). 
 48. See James E. Ward, Comments, “Is That Your Final Answer?” The Patchwork 
Jurisprudence Surrounding the Presumption Against Extraterritoriality, 70 U. CIN. L. 
REV. 715, 717–21 (2002). 
 49. Gerber, supra note 40, at 293. “Where conduct occurs within a state’s territory . . . 
the nexus is close, obvious and uncontested.” Id. at 290. 
 50. See generally American Banana v. United Fruit Co., 213 U.S. 347 (1909). 
 51. Ward, supra note 48, at 718 (explaining that the methodology in American Ba-
nana is “pure conflict of laws analysis based on vested rights and territoriality,” and in 
accordance with its philosophy that “every nation possesses an exclusive sovereignty and 
jurisdiction within its own country . . . the legality of acts are to be determined wholly by 
the law of the country where the act is done.”). 
 52. Id. at 719. 
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across national borders.53 Business practices that spanned borders began 
to raise questions about which national laws applied.54 The result was 
increased international acceptance of the “objective territorial principle,” 
which establishes the state’s jurisdiction over crimes begun outside the 
state’s territory but which cause injury within it.55 
As the volume of transnational trading grew, the “effects principle” 
developed to deal with the issue of antitrust’s extraterritorial applica-
tion.56 The leading case on the issue was United States v. Aluminum Co. 
of America (Alcoa).57 A Canadian subsidiary of Alcoa transacted all of 
Alcoa’s international business; it entered into an international cartel ar-
rangement to fix aluminum prices worldwide, but none of the antitrust 
acts occurred within U.S. territorial boundaries.58 The U.S. Justice De-
partment alleged antitrust violations in the form of effects experienced 
within the United States.59 Judge Learned Hand’s opinion stated “it is 
settled law . . . that any state may impose liabilities, even upon persons 
not within its allegiance, for conduct outside its borders that has conse-
quences within its borders that the state reprehends . . . .”60 The court 
found the Sherman Act applicable to foreign conduct when it was “in-
tended to affect imports and did affect them.”61 This principle came to be 
highly resented by other nations, although resistance has weakened as 
more of them have adopted the concept of applying their own laws be-
yond their borders.62 
This exercise of extraterritoriality has been constrained over the years 
(to a greater or lesser extent) by the principle of comity63 or “reasonable-
                                                                                                             
 53. Gerber, supra note 40, at 293. 
 54. Id. 
 55. Id. (“This concept appeared as a logical and appropriate extension of the territori-
ality idea, and it created few difficulties, because as originally conceived, its scope was 
narrow: it applied only when the consequences of conduct could be ‘localized.’”). 
 56. Id. at 290–91 (“It is now generally accepted that a state may prescribe norms 
where conduct has particular kinds of effects within its territory, regardless of where the 
conduct takes place.”). 
 57. United States v. Aluminum Co. of America (Alcoa), 148 F.2d 416 (2d Cir. 1945). 
 58. Ward, supra note 48, at 719. 
 59. Alcoa, 148 F.2d at 422–23. 
 60. Id. at 443. The decision has nearly the stature of a Supreme Court case because 
the Supreme Court had certified it to be heard by the Second Circuit. Marina Lao, Re-
claiming a Role for Intent Evidence in Monopolization Analysis, 54 AM. U. L. REV. 151, 
160 n.42 (2004). 
 61. Alcoa, 148 F.2d at 444. 
 62. Gerber, supra note 40, at 294–95. 
 63. Comity is “the recognition which one nation allows within its territory to the leg-
islative, executive or judicial acts of another nation, having due regard both to interna-
2006] THE FTAIA AND EXTRATERRITORIAL EFFECTS 813 
ness.”64 While the government does consider comity before bringing 
cases against foreign nationals under federal antitrust laws, the majority 
of litigated cases involving foreign nationals, and therefore the develop-
ment of the case law applying the principle of comity and its “rise and 
fall” since the 1970s, have been centered in private antitrust litigation.65 
The high point for comity was Timberlane Lumber Co. v. Bank of 
America.66 The effects test had a number of shortcomings, such as ignor-
ing the concerns of foreign governments.67 In Timberlane, the Ninth Cir-
cuit set out a balancing test that took those interests into consideration.68 
The plaintiff, a U.S. company, alleged that the bank had conspired with 
officials in Honduras to monopolize the timber industry.69 What made it 
different from American Banana and Alcoa was that the alleged antitrust 
activity took place entirely abroad (in Honduras), it involved only for-
eign citizens, and the economic impact was felt primarily in Honduras.70 
The court said that an effect on U.S. commerce was necessary but not 
                                                                                                             
tional duty and convenience, and to the rights of its own citizens.” Hilton v. Guyot, 159 
U.S. 113, 163–64 (1895). 
 64. Gerber, supra note 40, at 291. Gerber points out that the principle has been con-
strained in two ways: “One is to define more narrowly the kinds of effects required for 
the assertion of jurisdiction,” as done by the FTAIA, and, two, by using “balancing” or 
“reasonableness” factors in determining “whether there is prescriptive authority over 
foreign conduct or whether such authority should be exercised.” Id. at 295. 
 65. Spencer Weber Waller, The Twilight of Comity, 38 COLUM. J. TRANSNAT’L L. 563, 
566, 568 (2000) [hereinafter Waller, Twilight] (explaining that the need to apply comity 
arose because private litigants otherwise lacked incentive to consider the national interest 
in deciding whether to bring suits against foreign defendants). See also Wood, supra note 
40, at 299 (noting that, notwithstanding substantive convergence on the law, “objections 
to extraterritorial enforcement, based on procedural grounds, continued,” and observing 
that “the remaining problems in this area tended to arise from private litigation in the 
United States, rather than government litigation.”). 
 66. Timberlane Lumber Co. v. Bank of America, 549 F.2d 597 (9th Cir. 1976); Elea-
nor Fox, Testimony before the Antitrust Modernization Commission, Hearings on Inter-
national Issues, § III (Feb. 15, 2006), http://www.amc.gov/commission_hearings/inter 
national_antitrust.htm [hereinafter Fox, Testimony] (referring to Timberlane as “the par-
ent of U.S. antitrust comity ‘doctrine’ ”). 
 67. 3 VED P. NANDA, TRANSNATIONAL BUSINESS TRANSACTIONS § 13:3 (2005). 
 68. Id. The Timberlane test weighs (1) “the degree of conflict with foreign law or 
policy,” (2) the nationality or allegiance of the parties and the locations or principal 
places of businesses or corporations,” (3) “the extent to which enforcement by either state 
can be expected to achieve compliance,” (4) “the relative significance of effects on the 
United States as compared with those elsewhere,” (5) “the extent to which there is ex-
plicit purpose to harm or affect American commerce,” (6) “the foreseeability of such 
effect,” and (7) “the relative importance to the violations charged of conduct within the 
United States as compared with conduct abroad.” Timberlane, 549 F.2d at 614. 
 69. Timberlane, 549 F.2d at 601. 
 70. Ward, supra note 48, at 721. 
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sufficient to determine whether the United States should assert jurisdic-
tion.71 Instead, courts should look to whether the “interests of, and links 
to, the United States—including the magnitude of the effect on American 
foreign commerce—are sufficiently strong, vis-à-vis those of other na-
tions, to justify an assertion of extraterritorial authority.”72 This test ulti-
mately found its way into the Restatement (Third) of Foreign Relations 
Law,73 and was seen as a middle-of-the-road approach between American 
Banana and Alcoa,74 but it came to be criticized as leaving too much dis-
cretion over political decisions to judges, rather than to the executive and 
legislative branches where such decisions arguably belong.75 
The Supreme Court’s 1993 decision in Hartford Fire Insurance Co. v. 
California76 signaled a major shift in application of the balancing doc-
trine.77 There, the Court established a new principle of prescriptive juris-
diction, holding that balancing issues are relevant, if at all, only where 
there is a “true conflict” between U.S. and foreign law.78 Plaintiffs had 
brought Sherman Act claims against domestic insurers and foreign rein-
surers, alleging that they cut back the scope of insurance coverage for 
U.S. buyers through illegal agreements.79 The U.K.-based defendants 
asserted their conduct was lawful under British law, and they moved to 
dismiss the complaint for lack of jurisdiction and for reasons of comity.80 
But the Supreme Court held that there was jurisdiction, because the for-
eign conduct produced substantial effects in the United States.81 The 
Court avoided comity balancing, holding that comity should be consid-
ered only where there is a true conflict between U.S. and U.K. law.82 A 
“true conflict” would be one in which compliance with one nation’s law 
would require one to violate the law of another,83 but no conflict exists 
                                                                                                             
 71. Timberlane, 549 F.2d at 613. 
 72. Id. 
 73. William S. Dodge, Extraterritoriality and Conflict-of-Laws Theory: An Argument 
for Judicial Unilateralism, 39 HARV. INT’L L.J. 101, 130 (1998). 
 74. Ward, supra note 48, at 721. 
 75. John Byron Sandage, Note, Forum Non Conveniens and the Extraterritorial Ap-
plication of United States Antitrust Law, 94 YALE L.J. 1693, 1699–1701 (1985). 
 76. Hartford Fire Insurance Co. v. California, 509 U.S. 764 (1993). 
 77. Gerber, supra note 40, at 296. 
 78. Id. at 296.  
 79. See Eleanor M. Fox, National Law, Global Markets, and Hartford: Eyes Wide 
Shut, 68 ANTITRUST L.J. 73, 74 (2000). 
 80. Id. at 75. 
 81. Hartford Fire, 509 U.S. at 796. 
 82. Harry First, Empagran and the International Reach of U.S. Antitrust Laws, 21 
NYSBA ANTITRUST L. SEC. SYMP. 26 (2005) [hereinafter First, SYMPOSIUM]. 
 83. Gerber, supra note 40, at 296. 
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when the laws of both countries can be complied with at the same time.84 
Comity was “virtually eliminated” in such cases85—until Empagran I. 
Justice Scalia wrote the dissenting opinion in Hartford Fire, and we will 
see echoes of that dissent in the Court’s Empagran opinion.86 
Empagran and the circuit split over the proper interpretation of the 
FTAIA gave the Supreme Court the opportunity to again address the ex-
traterritorial reach of the Sherman Act.87 Professor Harry First has said 
that it appears the Court wanted to revisit Hartford Fire and the approach 
taken by Justice Scalia in his dissent.88 The situation was now compli-
cated by foreign parties suing other foreign parties where their injuries 
did not have an effect in the United States.89 
III. THE FOREIGN TRADE ANTITRUST IMPROVEMENT ACT 
The Foreign Trade Antitrust Improvement Act was enacted in 1982,90 
adding section 7 to the Sherman Act91 and exempting from the Sherman 
                                                                                                             
 84. Hartford Fire, 509 U.S. at 799. British law did not require the insurance compa-
nies to violate U.S. law, and so it was not impossible to comply with the laws of both 
countries. First, SYMPOSIUM, supra note 82. 
 85. Waller, Twilight, supra note 65, at 569. See also Gerber, supra note 40, at 296 
(arguing that “by severely reducing conceptual constraints on U.S. jurisdictional claims, 
the Court has undermined decades of efforts to develop a more effective and internation-
ally acceptable jurisdictional mechanism” and pointing out that some lower courts have 
interpreted the decision narrowly). 
 86. Eleanor M. Fox, Remedies and the Courage of Convictions in a Globalized 
World: How Globalization Corrupts Relief, 80 TUL. L. REV. 571, 578 (2005) [hereinafter 
Fox, Remedies]. 
 87. 1 NANDA & PANSIUS, supra note 5 (pointing out that although the impact of the 
FTAIA on foreign plaintiffs had not been extensively litigated until recently, that 
changed with the contrasting approaches of the decisions of the Fifth Circuit in Den Nor-
ske and the Second Circuit in Kruman). 
 88. First, SYMPOSIUM, supra note 82, at 27. 
 89. Transcript of Oral Argument at *15, F. Hoffman-La Roche, Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). Assistant Attorney General R. 
Hewitt Pate stated that there were no cases prior to 1982, when the FTAIA was enacted, 
in which a foreign cartel injured parties in the United States and separately injured people 
abroad. Id. 
 90. Foreign Trade Antitrust Improvement Act, 15 U.S.C. § 6(a) (1982). The FTAIA 
provides: 
Conduct involving trade or commerce with foreign nations. 
This Act shall not apply to conduct involving trade or commerce (other than 
import trade or import commerce) with foreign nations unless— 
(1) such conduct has a direct, substantial, and reasonably foreseeable effect—  
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Act’s reach export activity that does not have a negative effect on U.S. 
commerce.92 In effect, it legalized “export cartels.”93 The Court in Em-
pagran explained the operation of the statute this way: 
[The] language initially lays down a general rule placing all (non-
import) activity involving foreign commerce outside the Sherman Act’s 
reach. It then brings such conduct back within the Sherman Act’s reach 
provided that the conduct both (1) sufficiently affects American com-
merce, i.e., it has a “direct, substantial, and reasonably foreseeable ef-
fect” on American domestic, import, or (certain) export commerce, and 
(2) has an effect of a kind that antitrust law considers harmful, i.e., the 
“effect” must “giv[e] rise to a [Sherman Act] claim.”94 
Thus, it endorsed the “effects test,” requiring that the effects of the 
anticompetitive conduct on U.S. commerce “give rise to a claim” under 
the antitrust laws.95 But it turns out that “a” doesn’t always mean “a”; 
                                                                                                             
 (A) on trade or commerce which is not trade or commerce with for-
eign nations, or on import trade or import commerce with foreign na-
tions; or 
(B) on export trade or export commerce with foreign nations, of a 
person engaged in such trade or commerce in the United States; and 
(2) such effect gives rise to a claim under the provisions of sections 1 to 7 of 
this title, other than this section. 
If sections 1 to 7 of this title apply to such conduct only because of the opera-
tion of paragraph (1)(B), then sections 1 to 7 of this title shall apply to such 
conduct only for injury to export business in the United States. 
Id. 
 91. Sherman Act, 1 U.S.C. § 1 (1890). See also 1 NANDA & PANSIUS, supra note 5. 
 92. Empagran S.A. v. F. Hoffman-La Roche, Ltd., 315 F.3d 338, 345 (D.C. Cir. 
2003), citing Hartford Fire Insurance Co. v. California, 509 U.S. 764, 796–97 n.23 
(1993). 
 93. It is helpful to understand the political and economic background of the time: The 
FTAIA was “[e]nacted during a fit of industrial-policy enthusiasm and anti-Japanese 
hysteria[;] it legalizes U.S. export cartels—that is, price agreements and output restric-
tions that would earn their practitioners prison time if targeted at American consumers.” 
Michael Greve & Richard Epstein, Foreign Headaches, NAT’L L.J., July 12, 2004, avail-
able at http://www.federalismproject.org/masterpages/publications/foreign%20headaches 
.html. An export cartel is composed of a group of producers within a single country 
whose conduct is directed solely at foreign markets. James R. Atwood, Conflicts of Juris-
diction in the Antitrust Field: The Example of Export Cartels, 50 L. & CONTEMP. PROBS. 
153, 154 (1987). 
 94. Empagran I, 542 U.S. at 161 (internal citations omitted). 
 95. Empagran, 315 F.3d at 344. 
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sometimes it means “the.”96 Congress did not define it, leaving courts to 
ponder97 whether the claim necessarily had to be the plaintiff’s own, or 
whether it was only necessary that someone had a claim.98 
The district court’s decision applied the “restrictive view” of the 
FTAIA, that is, a plaintiff’s claim is restricted to injuries that actually 
arise from the effects of defendants’ antitrust conduct on U.S. com-
merce.99 The plaintiffs had sought a determination based on the “less re-
strictive view,”100 which would provide the court with jurisdiction over a 
foreign plaintiff suing a foreign defendant if any U.S. plaintiff—even the 
government—has a hypothetical cause of action (that is, a claim that 
some party could bring, even if it has not).101 On appeal, rather than 
adopting the position of the Fifth Circuit or the Second Circuit, the D.C. 
                                                                                                             
 96. In fact, entire articles have been written about the ambiguity of the word “a” in 
this context. See generally Whittaker & Thomas, supra note 15; Mehra, Anachronism, 
supra note 28. Judge Higgenbotham wrote, “The word ‘a’ has a simple and universally 
understood meaning. It is the indefinite article . . . . If the drafters of FTAIA had wished 
to say ‘the claim’ instead of ‘a claim,’ they certainly would have.” Den Norske Stats 
Oljeselskap As v. HeereMac Vof, 241 F.3d 420, 432 (5th Cir. 2001) (Higgenbotham, J., 
dissenting). 
 97. United States v. LSL Biotechnologies, 379 F.3d 672, 678 (9th Cir. 2004) (“Fed-
eral courts did not shower the FTAIA with attention for the first decade after its enact-
ment. But in the last ten years, and in particular the last five years, the case reporters have 
steadily filled with decisions interpreting this previously obscure statute.”). 
 98. Mehra, Anachronism, supra note 28 (“In other words, even if the plaintiff’s claim 
need not arise from the domestic effect, there must be a potential Sherman Act claim that 
another private party could bring arising from that effect.”). 
 99. Empagran, 315 F.3d at 340 (“The District Court held that, under FTAIA, a plain-
tiff must establish that the injuries it seeks to remedy actually arose from the anticompeti-
tive effects of the defendants’ conduct on United States commerce. In other words, it is 
not enough for a plaintiff to show that other persons were injured by such United States 
effects; the United States effects themselves must give rise to plaintiff’s claim. This re-
strictive view of FTAIA’s jurisdictional reach finds support in the Fifth Circuit.”). See 
also Den Norske Stats Oljeselskap As v. HeereMac Vof, 241 F.3d 420 (5th Cir. 2001). 
 100. Empagran, 315 F.3d at 340–41 (“[Plaintiffs] contend that the District Court mis-
construed FTAIA . . . according to [plaintiffs], Congress did not limit jurisdiction to the 
‘the same claim’ as that on which the jurisdictional effects are based. Rather, Congress 
provided only that ‘a’ claim cognizable under the Sherman Act must exist. Once a juris-
dictional nexus exists, FTAIA does not limit the types of plaintiffs who may seek relief. 
Thus, according to [plaintiffs], it does not matter that the transactions in which they pur-
chased vitamins took place outside of U.S. commerce. This less restrictive view of 
FTAIA’s jurisdictional reach finds support in the Second Circuit.”) (emphasis in origi-
nal). See also Kruman v. Christie’s Int’l PLC, 284 F.3d 384 (2d Cir. 2002). 
 101. Here the claim was not hypothetical; the government and numerous private plain-
tiffs had already sustained their cause of action under the Sherman Act in the original 
domestic Vitamins litigations. First, Vitamins, supra note 12, at 713–19; Empagran, 315 
F.3d at 352. 
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Circuit carved out yet another approach, although one closer to that of 
the Second Circuit: where the anticompetitive conduct has an effect on 
U.S. commerce, that conduct must give rise to a claim by someone (not 
necessarily the plaintiff); a government cause of action is not in itself a 
sufficient basis for jurisdiction.102 Because the cartel’s actions had obvi-
ously given rise to antitrust claims by U.S. parties,103 the circuit court 
reversed the district court’s decision and held that it had subject matter 
jurisdiction104 (and that the plaintiffs had standing to bring their 
claims),105 thus setting the stage for Supreme Court review of what was 
now a three-way circuit split. 
                                                                                                             
 102. Empagran, 315 F.3d at 350. The court held: 
Our view of the statute falls somewhere between the views of the Fifth and 
Second Circuits, albeit somewhat closer to the latter than the former. We hold 
that, where the anticompetitive conduct has the requisite effect on United States 
commerce, FTAIA permits suits by foreign plaintiffs who are injured solely by 
that conduct’s effect on foreign commerce. The anticompetitive conduct itself 
must violate the Sherman Act and the conduct’s harmful effect on United States 
commerce must give rise to “a claim” by someone, even if not the foreign 
plaintiff who is before the court. Thus, the conduct’s domestic effect must do 
more than give rise to a government action for violation of the Sherman Act, 
but it need not necessarily give rise to the particular plaintiff’s private claim. 
This interpretation has the appeal of literalism. 
Id. 
 103. See First, Vitamins, supra note 12, at 718–19. 
 104. Empagran, 315 F.3d at 357, 359. The court did not entertain the plaintiffs’ alter-
native theory that their injuries were a consequence of defendants’ harm to U.S. com-
merce. The theory was: 
[Plaintiffs’] complaint states a viable cause of action even under the District 
Court’s restrictive view of FTAIA. [Plaintiffs] contend that [defendants] caused 
injury to purchasers outside of the United States as a result of the anticompeti-
tive effects of price changes and supply shifts in United States commerce. Not 
only was United States commerce directly affected by the worldwide conspir-
acy, [plaintiffs] say, but the cartel raised prices around the world in order to 
keep prices in equilibrium with United States prices in order to avoid a system 
of arbitrage. Thus, according to [plaintiffs], the “fixed” United States prices 
acted as a benchmark for the world’s vitamin prices in other markets. On this 
view of the alleged facts, [plaintiffs] claim that the foreign plaintiffs were in-
jured as a direct result of the increases in United States prices even though they 
bought vitamins abroad.  
Id. at 341 (emphasis in original). The Supreme Court ultimately remanded for considera-
tion of this point. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 
155, 175 (2004). 
 105. Although the District Court did not rule on the issue of antitrust standing, the 
Appeals Court reviewed it and found that the plaintiffs’ injury was an injury of the type 
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With the Fifth Circuit holding a “restrictive” view, the Second Circuit 
holding a “less restrictive” view, and the D.C. Circuit carving out a view 
somewhere between the two, the Supreme Court granted certiorari on 
this very narrow ground: whether the FTAIA exception to the Sherman 
Act applies to a situation in which foreign plaintiffs allege a wholly for-
eign injury, that is, one not dependent on injury to U.S. commerce.106 
Why were there so many different interpretations of the FTAIA? It is 
widely considered to be a poorly drafted statute,107 full of “double nega-
tives, triple negatives, carve-ins and carve-outs and a proviso that is an 
exception to one of the exceptions,”108 and even its legislative history is 
contradictory.109 But, according to the Supreme Court’s interpretation of 
                                                                                                             
that the antitrust laws are intended to prevent (antitrust injury). Empagran, 315 F.3d at 
357 (“The foreign purchasers have constitutional standing. They allege that they suffered 
injury-in-fact when they paid inflated prices for vitamins directly to the defendants . . . 
There is no dispute that the foreign plaintiffs in this case have been injured by paying 
inflated prices for vitamins.”). 
 106. Empagran I, 542 U.S. at 160. 
 107. Turicentro, S.A. v. American Airlines, Inc., 303 F.3d 293, 300 (3d Cir. 2002) 
(describing the statute as “inelegantly phrased” and referring to its “convoluted lan-
guage”). One commentator has “translated” the FTAIA into “human readable form” thus: 
Plaintiffs (may) have a claim involving foreign commerce under the Sherman 
Act if: 
1.  the conduct in question has a direct, substantial, and reasonably foreseeable 
effect 
   a. on domestic commerce or on import commerce; or 
   b. on American export commerce; and 
2. such effect gives rise to a claim under the Sherman Act. 
U.S. Jurisdiction Over Foreign Antitrust Claims After Empagran: Many Questions Re-
main Open, Latham & Watkins, July 8, 2004, at 1, 2, http://www.lw.com/resource/ 
Publications/_pdf/pub1032_1.pdf. 
 108. Shenefield, SYMPOSIUM, supra note 34, at 29. 
 109. H.R. REP. No. 97-686 (1982), reprinted in 1982 U.S.C.C.A.N. 2487. See also 
Empagran, 315 F.3d at 352–56, for its review of the legislative history. Although the 
Supreme Court appeared to find the statute’s history definitive, the circuit court found 
much in the record that each side could rely on. Salil Mehra breaks down the House tes-
timony in a table to show that one can find statements to support precisely opposite 
points of view. Salil K. Mehra, More is Less: A Law-and-Economics Approach to the 
International Scope of Private Antitrust Enforcement, 77 TEMP. L. REV. 47, 65–66 (2004) 
[hereinafter Mehra, More is Less] (arguing that “[t]he ‘legislative history is clear’ argu-
ment is deeply flawed . . . .” Not only is the testimony not clear, but “[t]he subcommittee 
that originally considered the bill rejected a Business Roundtable-proposed version of the 
language at issue that would have limited recovery to ‘injury so caused in the United 
States.’ This failed version of the FTAIA would have enacted the ‘narrow view.’”). 
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the legislative history, Congress’ intent was to “make clear to American 
exporters (and to firms doing business abroad) that the Sherman Act does 
not prevent them from entering into business arrangements (say, joint-
selling arrangements), however anticompetitive, as long as those ar-
rangements adversely affect only foreign markets.”110 
From the text of the House Report it appears that the FTAIA was not 
limited to conduct involving U.S. exports.111 The bill’s original language 
referred only to “export” trade, but it was broadened to “other than im-
port” trade.112 It has been argued, however, that its language does not 
support providing additional causes of action or additional standing, but 
only limits the Sherman Act’s jurisdiction.113 
Given the lack of unanimity on the interpretation of the FTAIA, three 
policy arguments have dominated the debate: (1) deterrence, (2) burden 
on the courts, and (3) the impact on development of antitrust regimes in 
countries that either have no antitrust laws or have underdeveloped sys-
tems. 
Deterrence has been the most hotly debated of these arguments, with 
advocates on each side of the issue claiming it supports their position. On 
one side is the view that opening U.S. courtroom doors to a potential 
flood of additional lawsuits will have an enormously detrimental effect 
on deterrence.114 The U.S. government’s amnesty program reduces the 
punishment for the first cartel member to come forward with information 
                                                                                                             
 110. Empagran I, 542 U.S. at 161. 
 111. H.R. REP. NO.67–686. David Gerber points out that “[g]iven that Congress often 
does not specify the geographical scope of legislation . . . the courts must resort to pre-
sumptions regarding congressional intent.” Gerber, supra note 40, at 297. 
 112. A House Report noted that the House Judiciary Committee broadened the original 
bill, which referred only to “export trade or export commerce,” and changed that lan-
guage to “trade or commerce (other than import trade or import commerce).” The Empa-
gran Court noted that the Committee “did so deliberately to include commerce that did 
not involve American exports but which was wholly foreign.” Empagran I, 542 U.S. at 
163. 
 113. Mehra, Ends and Means, supra note 37, at 349 (explaining that “the FTAIA is 
drafted as a limitation on the Sherman Antitrust Act’s jurisdiction.”). The point was made 
by Assistant Att’y Gen. R. Hewitt Pate: 
 [T]he statute cannot on its terms expand jurisdiction by reason of its language, 
which begins with a statement that the antitrust laws shall not apply, and then 
puts the plaintiff back where it was prior to the FTAIA if certain conditions are 
met. In no case can the statute operate to give additional causes of action or 
create additional standing on behalf of parties who didn’t have it prior to the 
FTAIA. 
Transcript of Oral Argument at *18, Empagran I, 542 U.S. 155 (No. 03-724). 
 114. See infra text accompanying notes 116–20. 
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about a cartel’s activities; the argument is that companies, when consid-
ering taking advantage of the amnesty program, assess their financial 
exposure to other governmental and private actions flowing from the 
criminal admission.115 But if their civil liabilities are almost certain to be 
magnified because of an increase in the pool of potential (non-U.S.) 
plaintiffs, or if that risk, at minimum, makes it difficult even to estimate 
the potential damages, potential whistle-blowers may decline to come 
forward, and detection of the cartel’s illegal activities will be ham-
pered.116 The U.S. Department of Justice submitted an amicus brief argu-
ing that the Court of Appeals’ interpretation of the FTAIA would “sub-
stantially interfere” with the government’s enforcement of the antitrust 
laws.117 In fact, it said, “the theoretical possibility of additional deter-
                                                                                                             
 115. Since 1993, when the DOJ revised its leniency policy, the “U.S. amnesty pro-
gramme has become ‘the most effective generator of international cartel cases’ for the 
division and ‘unquestionably, the single greatest investigative tool available to anti-cartel 
enforcers’.” William J. Baer, Tim Frazer & Luc Gyselen, International Leniency Re-
gimes: New Developments and Strategic Implications, GLOBAL COMPETITION REV., 
http://globalcompetitionreview.com/ara/international.cfm (last visited Mar. 5, 2006) (cit-
ing U.S. Dept. of Justice, Status Report: An Overview of Recent Developments in the 
Antitrust Division’s Criminal Enforcement Program (2004), http://www.usdoj.gov/atr/ 
public/guidelines/202531.htm; Address by Scott D. Hammond, Director of Criminal En-
forcement, Antitrust Division, U.S. Dept. of Justice, Detecting and Deterring Cartel Ac-
tivity Through an Effective Leniency Program, Nov. 21–22, 2000, http://www.usdoj.gov/ 
atr/public/speeches/9928.htm). The DOJ is so concerned about protecting the viability of 
its amnesty program that “it will not share information provided by an amnesty applicant 
with foreign antitrust enforcement authorities (unless permitted by the applicant).” Id. 
(citing Address by Gary R. Spratling, Deputy Asst. Att’y Gen., Antitrust Division, U.S. 
Dept. of Justice, Making Companies an Offer They Shouldn’t Refuse: The Antitrust Divi-
sion’s Corporate Leniency Policy—An Update, Feb. 16, 1999, available at http://www. 
usdoj.gov/atr/public/speeches/2247.htm). Observers have noted the irony that the De-
partment of Justice sided here “with the very vitamins defendants it had prosecuted.” Joe 
Sims, U.S. Supreme Court Tackles International Antitrust Issues, Jones Day, Aug. 2004, 
http://www.jonesday.com/pubs/pubs_detail.aspx?pubID=S1032. 
 116. William E. Kovacic, Extraterritoriality, Institutions, and Convergence in Interna-
tional Competition Policy, 97 AM. SOC’Y INT’L L. PROC. 309, 311 n.9 (2003) [hereinafter 
Kovacic, Extraterritoriality]. See also Donald C. Klawiter, Global Cartel Enforcement in 
2004: Penalties, Leniency Considerations and Coordination, GLOBAL COMPETITION REV., 
The Antitrust Review of the Americas 2004: US Cartels, http://www.globalcompetition 
review.com/ara/us_cartels.cfm (arguing, before the Supreme Court decision, that if Em-
pagran were upheld, “the damage risk increases several-fold and may create, for some 
companies, a significant disincentive to apply for leniency.”). 
 117. Brief for the United States as Amicus Curiae Supporting Petitioners at 20–21, 
Empagran I, 542 U.S. 155 (No. 03-724) (arguing that the amnesty program has been 
more valuable to the Department of Justice “than all of the Division’s search warrants, 
secret audio or videotapes, and FBI interrogations combined . . . Faced with joint and 
several liability for co-conspirators’ illegal acts all over the world, a conspirator could not 
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rence . . . would come only at the expense of weakening the ability of the 
United States government to discover the wrongdoing in the first 
place.”118 Governments of a number of other countries with developed 
antitrust regimes filed briefs taking the same position.119 
On the other side is the view that the threat of treble damages exerts a 
powerful deterrent effect on potential antitrust violators, from which 
American consumers benefit. This view was articulated in the majority 
opinions in Pfizer v. Government of India120 and Kruman v. Christie’s 
Int’l,121 and in Judge Patrick Higginbotham’s widely cited dissent in Den 
Norske v. HeereMac.122 The D.C. Circuit in Empagran found the deter-
rence argument to be “most compelling”123 in deciding that it should take 
the “less restrictive view” of the FTAIA, citing Judge Higginbotham’s 
opinion for the proposition that “a global price-fixing scheme could sus-
tain monopoly prices in the United States even in the face of domestic 
liability, since the profits from abroad would subsidize the U.S. opera-
tions.”124 
Another policy concern is the potential impact on U.S. courts if the 
FTAIA provided wider access to foreign plaintiffs. Observers predicted 
                                                                                                             
readily quantify its potential liability. The prospect of civil liability to all global victims 
would provide a significant disincentive to seek amnesty from the government.” The 
amnesty program, in the government’s judgment, “deters cartel behavior more effectively 
than any increase in private litigation after the cartel has been exposed,” and so deter-
rence is best maximized, they argue, “not by maximizing the potential number of private 
lawsuits, but by encouraging conspirators to seek amnesty and expose cartels in the first 
place.”). 
 118. Id. at 23. 
 119. See Brief of the United Kingdom in Support of Petitioners at 9–13, Empagran I, 
542 U.S. 155 (No. 03-724); Brief of the Governments of the Federal Republic of Ger-
many and Belgium as Amici Curiae in Support of Petitioners at 28–29, Empagran I, 542 
U.S. 155 (No. 03-724). 
 120. Pfizer Inc. v. Government of India, 434 U.S. 308, 314–15 (1978). 
 121. Kruman v. Christie’s Int’l PLC, 284 F.3d 384, 403 (2d Cir. 2002). 
 122. Den Norske Stats Oljeselskap As v. HeereMac Vof, 241 F.3d 420, 434–35 (5th 
Cir. 2001). 
 123. Empagran S.A. v. F. Hoffman-La Roche, Ltd., 315 F.3d 338, 355–57 (D.C. Cir. 
2003).  The D.C. Circuit said of the deterrence argument: 
We are persuaded that, if foreign plaintiffs could not enforce the antitrust laws 
with respect to the foreign effects of anticompetitive behavior, global conspir-
acy would be under-deterred, since the perpetrator might well retain the bene-
fits that the conspiracy accrued abroad . . . . The U.S. consumer would only 
gain, and would not lose, by enlisting enforcement by those harmed by the for-
eign effects of a global conspiracy. 
Id. at 356. 
 124. Id. at 256, quoting Den Norske, 241 F.3d at 435 (Higginbotham, J., dissenting). 
2006] THE FTAIA AND EXTRATERRITORIAL EFFECTS 823 
that already burdened courts would be forced to deal with extremely dif-
ficult cases involving complex procedural issues and factual inquiries.125 
The Sherman Act covers not only price-fixing, the adjudication of which 
is fairly straightforward, but also other more complex and subjective an-
titrust issues.126 If the FTAIA did not preclude jurisdiction over foreign 
plaintiffs whose antitrust claims were independent of U.S. effect, plain-
tiffs would be able to bring claims on any antitrust basis.127 
The third policy concern is that the extension of our antitrust reach into 
what should arguably be the jurisdiction of other states would retard the 
                                                                                                             
 125. Den Norske, 241 F.3d at 431 (“Any reading of the FTAIA authorizing jurisdic-
tion” in the case “would open U.S. courts to global claims on a scale never intended by 
Congress.”). The issue was raised in oral argument before the Supreme Court in Empa-
gran. Stephen M. Shapiro, attorney for petitioners-defendants, stated: 
[C]onsider global plaintiffs from 192 countries coming to the United States and 
asking a single district court judge to decide how much they’ve been over-
charged, how much competition there was locally, what trade barriers there 
were that might have prevented competition, calculate the damages for every 
man, woman, and child on the face of the Earth that perhaps . . . has an antitrust 
claim. 
Transcript of Oral Argument at *11, F. Hoffman-La Roche, Ltd. v. Empagran S.A. (Em-
pagran I), 542 U.S. 155 (2004) (No. 03-724). When a member of the court commented, 
“I suppose that’s the penalty for engaging in a worldwide conspiracy,” id. at *11–12, 
Shapiro answered, “But that penalty is imposed on our district court judges. They would  
. . . be forced to untangle these incredibly different procedural problems . . . . U.S. courts 
are not world courts equipped to do this.” Id. at *12. The U.S. government’s amicus cu-
riae brief argued the same point, noting that for plaintiffs who would be allowed to sue 
under the D.C. Circuit’s holding, the statutory inquiry would turn on claims and persons 
not before the court. “The court of appeals’ decision thus would thrust upon federal 
courts the potential for burdensome and protracted satellite litigation that is far removed 
from the claim before the court.” Brief for the United States as Amicus Curiae Support-
ing Petitioners at 23, F. Hoffman-La Roche Ltd. v. Empagran S.A., 542 U.S. 155 (2004) 
(No. 03-724). 
 126. Transcript of Oral Argument at *17–18, Empagran I, 542 U.S. 155 (No. 03-724). 
Attorney General R. Hewitt Pate argued, 
[T]o pursue this path would embroil the district courts around the country in all 
forms of satellite litigation, and it’s very important to recognize that this is not 
a test that would apply only to a notorious worldwide conspiracy, such as was 
at issue here, but would apply to rule of reason cases, joint venture cases, could 
apply even to Section 2 cases under the Sherman Act any time a plaintiff was 
able to allege that some other plaintiff somewhere suffered from a U.S. effect 
that was related to that conduct . . . . So in our judgment, the Court should pay 
attention to the practical realities of enforcement. 
Id. 
 127. Id. 
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development of antitrust law abroad.128 Europeans believe that an over-
broad application of U.S. jurisdiction would weaken private antitrust en-
forcement in Europe’s courts.129 Courts need a steady diet of cases to 
feed the development of a body of jurisprudence that will in turn facili-
tate private enforcement of antitrust claims; if those cases are attracted to 
the United States, foreign antitrust development will suffer.130 
IV. THE SUPREME COURT’S SURPRISING DECISION IN EMPAGRAN 
The Supreme Court’s decision in Empagran131 was less surprising than 
its reasoning.132 It reversed the D.C. Circuit and held that U.S. courts do 
not have subject matter jurisdiction over foreign plaintiffs when their 
claims are based on injuries that are independent of injury to U.S. plain-
tiffs,133 and remanded the case back to the circuit court for consideration 
of an alternate theory (which was not before it): whether there would be 
jurisdiction if the effects were not independent.134 
                                                                                                             
 128. Transcript of Oral Argument at *9, Empagran I, 542 U.S. 155 (No. 03-724). Peti-
tioners’ attorney Stephen M. Shapiro argued, 
Congress wanted the treble damage remedy to be available to protect our com-
merce. It expected other countries to adopt their own laws to deal with over-
charges within their own territories, and other nations, of course, have done just 
that. They’ve passed over 100 different pieces of legislation all around the 
world, from Albania to Zambia, we see new antitrust laws that have been 
passed, and it would discourage that process if the U.S. courts attempted to 
subsume all of these foreign overcharge disputes into our court system. 
Id. 
 129. See Margaret Bloom, Should Foreign Purchasers Have Access to U.S. Antitrust 
Damages Remedies? A Post-Empagran Perspective from Europe, 61 N.Y.U. ANN. SURV. 
AM. L. 433, 436 (2005). 
 130. Id. at 451. 
 131. The unanimous 8-0 decision was written by Justice Breyer. Empagran I, 542 U.S. 
155. Justice Sandra Day O’Connor recused herself because she owns shares of Procter & 
Gamble, which was seeking to bring suit on behalf of its foreign affiliates. Sandra Rubin, 
U.S. Antitrust Reach Shortened, NAT’L POST, June 30, 2004, available at 2004 WL 
85149593 (2004). 
 132. Ronald W. Davis, Empagran and International Cartels—A Comity of Errors, 19 
ANTITRUST 58, 59 (2004). 
 133. “[When t]he price-fixing conduct significantly and adversely affects both custom-
ers outside the United States and customers within the United States, but the adverse 
foreign effect is independent of any adverse effect . . . the FTAIA exception does not 
apply (and thus the Sherman Act does not apply) . . . .” Empagran I, 542 U.S. at 164. 
 134. Id. at 175. Thomas C. Goldstein, attorney for plaintiffs-appellants, has pointed out 
that Justice Breyer, in his opinion, wrote seven times, four of them in italics, that the 
Court was “only reaching the question of whether or not there is a claim when the injury 
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What was surprising was the Court’s approach. Justice Breyer took 
merely four short paragraphs of a 17-page opinion to deal with the lower 
courts’ linguistic disagreements over the meaning of the phrase “gives 
rise to a claim.”135 The opinion dismissed the basis for appellate dis-
agreement, holding that it makes just as much “linguistic sense to read 
the words ‘a claim’ as if they refer to the ‘plaintiffs’ claim’ or ‘the claim 
at issue’” as to read it to mean “a” claim, that is, anyone’s claim.136 Al-
though conceding that plaintiffs’ linguistic arguments might be the 
“more natural reading of the statutory language,” it concluded that con-
siderations of comity and history make it clear that was not the FTAIA’s 
intent.137 
Rather than parsing the words of the statute, the Court revisited the 
purpose of the FTAIA and found that Congress “designed the FTAIA to 
clarify, perhaps to limit, but not to expand in any significant way, the 
Sherman Act’s scope as applied to foreign commerce”138 and used the 
principle of comity to help determine the scope of the statute. Because an 
ambiguous statute must be construed to “avoid unreasonable interference 
with the sovereign authority of other nations,”139 and since the FTAIA 
was certainly ambiguous, it would be unreasonable to apply our antitrust 
laws to foreign conduct where that conduct did not cause domestic in-
jury.140 The justification, the Court said, for such “interference seems 
insubstantial.”141 
An example illustrates the Court’s concern with how a broad applica-
tion of the FTAIA could interfere in foreign affairs: It hypothesized a 
situation in which, under the circuit court’s theory, a buyer in a foreign 
country would be able to sue his own domestic supplier in a U.S. court  
simply by noting that unnamed third parties injured [in the United 
States] by the American [cartel member’s] conduct would also have a 
cause of action. Effectively, the United States courts would provide 
worldwide subject matter jurisdiction to any foreign suitor wishing to 
sue its own local supplier, but unhappy with its own sovereign’s provi-
sions for private antitrust enforcement, provided that a different plain-
                                                                                                             
overseas is completely unrelated to the injury of the United States.” Goldstein, Perspec-
tives, supra note 33. 
 135. Empagran I, 542 U.S. at 173–74. 
 136. Id. 
 137. Id. at 174. See also 1 NANDA & PANSIUS, supra note 5. 
 138. Empagran I, 542 U.S. at 169. This view has ample support in the House Report of 
the bill’s passage, as the Court noted. Id. 
 139. Id. at 164. The Court noted that harmony among those sovereign interests are 
more important “in today’s highly interdependent commercial world.” Id. at 165. 
 140. Id. 
 141. Id. 
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tiff had a cause of action against a different firm for injuries that were 
within U.S. [other-than-import] commerce.142  
The Court rejected the plaintiffs’ argument that because most other na-
tions have laws against price fixing,143 there is little likelihood that liti-
gating a price-fixing claim among foreign parties in the United States 
would interfere with the interests of other nations.144 It observed that 
there are still major differences among the antitrust laws of those coun-
tries that have antitrust regimes,145 and, while it is true that price-fixing is 
universally prohibited by countries that have antitrust laws, even those 
countries disagree dramatically about remedies. The application of our 
treble-damages provisions to conduct abroad, it noted, has “generated 
considerable controversy.”146 
The Supreme Court also dismissed the parties’ positions on deterrence. 
The Court noted that although the defendants’ arguments about deter-
rence made sense,147 so did those of the plaintiffs and the numerous 
“supporting enforcement-agency amici” who made arguments to the con-
                                                                                                             
 142. Id. at 166, quoting P. AREEDA & H. HOVENKAMP, ANTITRUST LAW § 273 (Supp. 
2003) (emphasis added). 
 143. See Shenefield, Coherence, supra note 38, at 402 (“[T]here exists today a rough 
consensus on certain—but not all—core antitrust principles. Most antitrust laws share 
certain features. Virtually all competition regimes prohibit cartels. Most also condemn 
certain kinds of vertical arrangements. Most forbid the exclusionary exploitation of mo-
nopoly or abuse of a dominant market position. In addition, prohibitions of anticompeti-
tive mergers are commonplace and many national laws also impose premerger notifica-
tion obligations.”). 
 144. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 155, 167 
(2004), citing Hartford Fire Insurance Co. v. California, 509 U.S. 764, 797–99 (1993). 
 145. See Kovacic, Extraterritoriality, supra note 116, at 309 (“A half-century ago, 
only one country, the United States, had antitrust statutes and active enforcement. Today 
over ninety jurisdictions have competition laws, and the number will exceed one hundred 
by the decade’s end.”). The differences, however, create problems for business and en-
forcement. “The multiplication of antitrust laws raises concerns that enforcement by ju-
risdictions with dissimilar substantive standards, procedures, and capabilities will dis-
courage legitimate business transactions and needlessly increase the cost of controlling 
anticompetitive conduct.” Id. Note also that there are countries that have no antitrust 
laws. 
 146. Empagran I, 542 U.S. at 167–68. The decision also noted briefs filed by Ger-
many, Canada and Japan that argued that to apply our remedies would “permit their citi-
zens to bypass their own less generous remedial schemes, thereby upsetting a balance of 
competing considerations that their own domestic antitrust laws embody” and would 
undermine their own antitrust enforcement policies “by diminishing foreign firms’ incen-
tive to cooperate with antitrust authorities in return for prosecutorial amnesty.” Id. 
 147. Id. at 174–75. 
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trary.148 It said that, despite considerable disagreement about the impact 
of private suits on the deterrence of illegal cartel behavior, there was not 
enough empirical evidence on either side,149 and it found neither argu-
ment ultimately convincing enough to alter its conclusion that the statute 
should be read narrowly.150 
                                                                                                             
 148. Id. at 174. Amici included the DOJ, the United Kingdom, Germany, Canada, and 
Japan. In particular, the U.S. government sees the exposure of foreign cartels to increased 
liability in the United States, especially through the treble damages provision, as a threat 
to its leniency programs. See William E. Kovacic, General Counsel, Federal Trade 
Commission, Private Participation in the Enforcement of Public Competition Laws (May 
15, 2003), http://www.ftc.gov/speeches/other/030514biicl.htm [hereinafter Kovacic, Pri-
vate Participation], for an in-depth discussion of the DOJ’s leniency program. Indeed, 
the Vitamins prosecution itself might not have been so successful if Rhone-Poulenc had 
not taken advantage of the leniency program and come forward with evidence against its 
fellow conspirators. First, Vitamins, supra note 12, at 715–16. 
 149. Empagran I, 542 U.S. at 174–75. One of the arguments is that leniency programs 
may become less effective as an anti-cartel device when private actions proliferate and 
the exposure to damages increases. See generally Kovacic, Private Participation, supra 
note 148 (“Private rights of action diminish, if not eliminate, the gate-keeping authority 
of public prosecutors and reduce their ability to control the development of policy by 
their selection of cases . . . and magnify the role of the courts in implementing the law.”). 
Kovacic continues: 
A court might seek to correct . . . perceived infirmities in the antitrust system 
by recourse to means directly within its control—namely, by modifying doc-
trine governing liability standards or by devising special doctrinal tests to 
evaluate the worthiness of private claims. [Arguably, this is what is happening 
here.] 
. . . [In particular, courts may] “equilibrate” the antitrust system . . . [by con-
structing] doctrinal tests under the rubric of  “standing” or “injury” that make it 
harder for the private party to pursue its case; . . . 
. . . [T]he hypothesis helps explain the modern evolution of U.S. antitrust doc-
trine. Since the mid-1970s, the U.S. courts have established relatively demand-
ing standards that private plaintiffs must satisfy to demonstrate that they have 
standing to press antitrust claims and have suffered “antitrust injury.” 
Id. But one commentator has argued that the differing goals of compensation and deter-
rence have been conflated in this argument. See Hannah L. Buxbaum, Jurisdictional Con-
flict in Global Antitrust Enforcement, 16 LOY. CONSUMER L. REV. 365, 373–74 (2004) 
(arguing that deterrence could be accomplished through public regulation rather than 
through private enforcement, and that although the United States has an additional inter-
est in permitting private plaintiffs to sue and receive compensation for their injuries, “it 
has no such interest with respect to foreign plaintiffs. The broad view therefore unneces-
sarily conflates the goal of compensation with the goal of deterrence.”). 
 150. Empagran I, 542 U.S. at 174–75. 
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Clearly the Court was concerned with judicial administration as 
well.151 The Court rejected as “unworkable” the plaintiffs’ suggestion 
that courts should take “account of comity considerations case by 
case.”152 The Court was concerned that the wide range of antitrust issues 
that courts would have to confront in applying foreign law could result in 
“procedural costs and delays [that] could themselves threaten interfer-
ence with a foreign nation’s ability to maintain the integrity of its own 
antitrust enforcement system.”153 
Ultimately, the Court said,  
[P]rinciples of prescriptive comity counsel against the Court of Ap-
peals’ interpretation of the FTAIA . . . [I]f America’s antitrust policies 
could not win their own way in the international marketplace for such 
ideas, Congress, we must assume, would not have tried to impose them, 
in an act of legal imperialism, through legislative fiat.154 
So, after years of debate among courts and scholars about the meaning 
of a single word in the FTAIA, and after hundreds of pages of arguments 
and briefs about the potential effect of its decision on deterrence of cartel 
behavior worldwide, the Court resurrected comity, an issue that had been 
dormant in antitrust law since Hartford Fire, to help construe the stat-
ute’s scope, even though the issue of comity was not even briefed or dis-





                                                                                                             
 151. Edward D. Cavanagh, Empagran and the International Reach of U.S. Antitrust 
Laws, 21 NYSBA ANTITRUST L. SEC. SYMP. 24 (2005) [hereinafter Cavanagh, SYMP-
OSIUM] (commenting that when Justice Rehnquist hears that a broad reading of the statute 
could invite a lot of plaintiffs to our courts, “his ears perk up very, very quickly, and he 
gets very interested in the argument.”). 
 152. Empagran I, 542 U.S. at 168. 
 153. Id. at 168–69. 
 154. Id. at 169. 
 155. It is not surprising that it was not, since Hartford Fire “pretty much kill[ed] off 
the concept of comity either in government cases or in private cases.” Waller, Courtroom, 
supra note 1, at 527. See also Fox, Remedies, supra note 86 (arguing that, “in its rhetoric, 
the Empagran Court launched a new life for comity.”). 
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V. ROUTE TO ANOTHER CIRCUIT SPLIT? 
Although the Court may have resolved the circuit split over the mean-
ing of “gives rise to a claim,”156 its decision did not resolve the parties’ 
dispute in Empagran,157 and it did little to provide guidance to lower 
courts.158 Indeed, it has made their jobs more complex.159 One scholar, in 
fact, has argued that the broad view of FTAIA construction—which 
would provide a court with jurisdiction over a foreign plaintiff as long as 
there were at least a hypothetical U.S. plaintiff with a cause of action—
would at least have the virtue of greater certainty: parties would be clear 
about their exposure, leading to more settlements and less litigation.160 
                                                                                                             
 156. Goldstein, Perspectives, supra note 33, at 4 (stating that “if we look behind [the 
decision] at what it is the Supreme Court thought it was doing, it thought it was resolving 
a circuit split between the Fifth Circuit’s Den Norske decision and D.C. Circuit’s ruling 
that ‘a claim’ meant ‘any person’s claim.’”). 
 157. Duke Law, supra note 23 (arguing that the decision “leaves the biggest question 
in the case undecided”). An article on Arnold & Porter LLP’s website immediately after 
the decision was published predicted: 
Future plaintiffs in virtually every international cartel case (as well as all man-
ner of non-cartel cases) will likely attempt to circumvent the Court’s Empagran 
ruling by asserting their participation in a “global” market—and arguing that, 
as a manner of economics, they could not have suffered injury “but for” the 
U.S. effects of any alleged anti-competitive conduct. 
The Supreme Court Decision in Empagran, Arnold & Porter LLP, June 2004, at 1, 5 (on 
file with the Brooklyn Journal of International Law). 
 158. See, e.g., U.S. Courts Reach Different Results on Issue Left Open by the U.S. Su-
preme Court’s Decision in Empagran, ANTITRUST L. NEWSL., July 2005, at 2, 
http://www.bakernet.com (follow “Resources,” “Law Alerts,” “Global Publications,” and 
choose “July 2005 North American Antitrust Law Newsletter” hyperlink). See also Per-
spectives on Empagran, ANTITRUST SOURCE, Sept. 2004, at 1, 6, http://www.abanet.org/ 
antitrust/source/sept04/Sep04Empagran.pdf (providing remarks by Jonathan S. Franklin, 
commenting that the business community “values certainty in legal applications, perhaps 
sometimes even over correct results.”) [hereinafter Franklin, Perspectives].  
 159. Perspectives on Empagran, ANTITRUST SOURCE, Sept. 2004, at 1, 2–3, http:// 
www.abanet.org/antitrust/source/sept04/Sep04Empagran.pdf (providing remarks by Ed-
ward Swaine) [hereinafter Swaine, Perspectives]. Swaine argues as follows:  
[The decision] failed to resolve any but the most extreme and easiest instances 
of foreign claims—that is, those claims that are completely estranged from U.S. 
effects, on which it is easiest to reach a view—and licensed a standardless in-
quiry into the relationship between antitrust markets. This will likely bedevil 
the lower courts. 
Id. 
 160. Mehra, More is Less, supra note 109, at 60. 
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But if the Court’s goal was to provide limits to U.S. extraterritorial an-
titrust jurisdiction,161 it did not do so clearly. The issue, as the Court 
framed it, encompassed only the most obvious, and perhaps only hypo-
thetical, situation.162 Still undecided was the question of whether foreign 
plaintiffs could bring an action where the foreign injury was not inde-
pendent of U.S. harm—that is, in the case when “the anticompetitive 
conduct’s domestic effects were linked to that foreign harm.”163 Courts in 
various circuits already have answered this question differently since 
Empagran.164 
In the months immediately following the publication of the decision, 
practitioners commenting on it accurately predicted that future actions 
would be framed to take advantage of the door that the Court had left 
open.165 They speculated that foreign plaintiffs would claim their injuries 
were dependent on the success of conspiracies affecting U.S. markets,166 
                                                                                                             
 161. 1 NANDA & PANSIUS, supra note 5. 
 162. Duke Law, supra note 23. The article contends: 
Arguably, for many products national markets can no longer be separated; in-
stead, there is one world market, and a price fixing conspiracy needs to be 
worldwide in order to succeed. Where markets are separable, it makes sense 
that each country should restrain itself to regulating its own market. Yet where 
such separation is impossible, the effects doctrine breaks down, and new, alter-
native instruments of determining and restricting jurisdiction will be necessary. 
The Court did not address this problem, yet in assuming separable markets it 
may have decided a case that was only hypothetical. 
Id. Edward D. Cavanagh speculates that Justice Breyer, who wrote Empagran, articulated 
the issue extremely narrowly to get the maximum number of justices to sign on to the 
opinion, and to achieve a unanimous result. Cavanagh, SYMPOSIUM, supra note 151, at 25. 
Even then, Justice Scalia, joined by Justice Thomas, apparently felt compelled to pen a 
short opinion stating they concurred because “the language of the statute is readily sus-
ceptible of the interpretation the Court provides . . . .” F. Hoffman-La Roche Ltd. v. Em-
pagran S.A. (Empagran I), 542 U.S. 155, 176 (2004) (Scalia, J., concurring). 
 163. Limiting the issue to the case in which the adverse foreign effect is independent of 
any domestic effect. Empagran I, 542 U.S. at 175. 
 164. See infra Part V. 
 165. See Sims, supra note 115 (predicting “[t]hat the plaintiffs’ bar will use it [the fact 
that the Court ‘left the door open a small crack’] to bring foreign antitrust claims seems 
virtually certain.”). 
 166. See Clifford Chance LLP, Recent Developments in Antitrust Litigation in the UK 
and the U.S., July 2004 (“It is certain that there will be no dearth of plaintiffs willing and 
able to test this reach [of the FTAIA exception] by claiming that their injury in world-
wide markets was dependent on the success of a conspiracy in US markets.”) (on file 
with the Brooklyn Journal of International Law). 
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leading lower courts to grapple with complex evidence of worldwide 
economic effects.167 
Indeed, a review of practitioners’ commentary immediately after the 
opinion was published showed an initial sense of relief tempered by a 
sense that much was still left to be determined. Among the most optimis-
tic were comments such as these: “good news for companies facing 
treble damages actions”168 and “defendants . . . are free from the threat 
that an entire worldwide class of potential plaintiffs can seek treble dam-
ages” in U.S. courts.169 Others observed that the questions left open were 
“sure to consume significant time and resources in the years ahead”170 
and speculated on the likelihood of a growth in litigation.171 But within 
                                                                                                             
 167. See U.S. Supreme Court Limits Application of U.S. Antitrust Laws to Foreign 
Applications, June 2004, Kelly Drye, http://www.kelleydrye.com/resource_center (type 
“Empagran” in Keyword search box). The writers predicted: 
In cases where the market is international, American plaintiffs’ lawyers will 
now plead in their complaints that the injury to foreign plaintiffs is linked to the 
domestic effects of the alleged violation. They will then work with their hired 
economists to develop evidence and arguments to support that allegation. The 
defense lawyers and their experts will seek to show the opposite. The lower 
courts will have to grapple with the meaning of this part of the Supreme 
Court’s opinion, in particular what evidence will be sufficient to trigger appli-
cation of the FTAIA. 
Id. 
 168. Arnold & Porter, supra note 157 (“This is good news for companies facing civil 
antitrust treble damages actions. However, the decision is not definitive. It leaves key 
questions unanswered about the viability of foreign purchaser claims in an allegedly 
‘global’ market where plaintiffs can claim some interrelationship, as a matter of econom-
ics, between the foreign and domestic effects of the underlying conduct.”). 
 169. Supreme Court Decides That Most Foreign Antitrust Plaintiffs Cannot Sue for 
Treble Damages Under the Sherman Act, Proskauer Rose LLP, June 2004, at 1, 2, 
http://www.proskauer.com/site_search_in (type “Sherman Act” in Keyword search box) 
(“The immediate effect of the decision in Empagran is that most defendants alleged to 
have engaged in global anticompetitive conduct—both United States firms and foreign 
firms—are free of the threat that an entire worldwide class of potential plaintiffs can seek 
treble damages and attorneys’ fees in the United States courts. In most cases, foreign 
purchasers from such defendants will be unable to recover their damages . . . even where 
there is proof that the defendants violated the Sherman Act and perhaps the competition 
laws of other countries.”). 
 170. New Supreme Court Decision Resolves Hotly-Disputed Issues of Antitrust Liabil-
ity Flowing From International Cartel Activity, Hughes Hubbard & Reed LLP, June 
2004, at 1, http://www.hugheshubbard.com/news.asp (follow “Publications” hyperlink). 
 171. F. Hoffman-La Roche Ltd. v. Empagran: Supreme Court Restricts Extraterritorial 
Reach of U.S. Antitrust Laws, Wilmer Cutler Pickering Hale & Dorr, June 2004, at 3, 
http://wilmerhale.com/publications (type “Empagran” in Keyword search box). The 
firm’s writers predicted: 
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only a few months, practitioners were beginning to anticipate what facts 
a plaintiff would have to plead to get past a motion to dismiss,172 and 
what further semantic parsing would be necessary.173 
What was not in question was that plaintiffs would exploit the ambi-
guities.174 As expected, plaintiffs in actions already before the courts 
quickly recast their claims to ensure that their injuries were seen as de-
pendent on U.S. effects.175 
A. Remand—Proximate Cause 
On remand, the D.C. Circuit took up the question still left open by the 
Supreme Court, namely, what was to be the standard in a case where the 
plaintiff’s injury was not independent? Would it be “but-for” causation, 
or something more?176 Plaintiffs framed their argument as follows: 
                                                                                                             
Empagran should put an end to most U.S. antitrust suits for injuries in foreign 
commerce premised on allegations that the unlawful conduct also affected U.S. 
commerce. We are, in particular, likely to have fewer cases in U.S. courts 
brought by consumers injured overseas as a result of global antitrust conspira-
cies . . . . We are, however, likely to see additional litigation about whether 
some plaintiffs that purchased overseas can sue in the United States if they can 
allege that their injuries were linked to effects on U.S. markets; and, if so, un-
der what circumstances, [sic] the courts might allow such claims. 
 172. See Sims, supra note 115 (“If a boilerplate statement that the alleged foreign in-
jury is linked to the alleged domestic injury is enough, then Empagran, unfortunately, 
may not have as great an effect in practice as it should . . . . One hopes that the Court of 
Appeals on remand in the Empagran case, and other courts in other cases, will require a 
significant factual showing.”). 
 173. See also Jane Whittaker, The Empagran Case: Closing the U.S. Courtroom 
Door?, Practical Law Company, Aug. 2004, http://competition.practicallaw.com/2-102-
8926 (“The apparent victory for the cartelists in Empagran may not be as conclusive as 
they would wish. The case may have moved on from the meaning of ‘a claim’ to the in-
terpretation of what amounts to independent foreign injury or indeed quantifying the 
word ‘entirely’ which seems to qualify the level of independence . . . . Certainly Empa-
gran is not the end of the story.”). See also Tony Woodgate & Jane Jellis, Private EC 
Antitrust Enforcement, GLOBAL COMPETITION REV., http://www.globalcompetitionreview. 
com/ear/private.cfm (last visited Mar. 5, 2006) (“Commentators on both sides of the At-
lantic await, [sic] how this ‘facilitation’ test will be interpreted.”). 
 174. Rubin, supra note 131 (quoting Bill Rowley, head of the antitrust group at 
McMillan Binch, as stating, “There is no more inventive a bunch of people in the world 
than U.S. plaintiff counsel and they will quickly be able to make very convincing argu-
ments.”). 
 175. See, e.g., BHP New Zealand Ltd. v. UCAR International, Inc., 106 F. App’x. 138 
(3d Cir. 2004) (not precedential). 
 176. Thomas C. Goldstein, who argued the plaintiffs’ case, laid out the issue at the 
ABA Section of Antitrust Law Brown Bag Luncheon discussion: “[W]hat degree of rela-
tionship is required . . . . Is it ‘but for’ causation? Is it something else? How intrinsic does 
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Because the [defendants’] product (vitamins) was fungible and globally 
marketed, they were able to maintain super-competitive prices abroad 
only by maintaining super-competitive prices in the United States as 
well. Otherwise, overseas purchasers would have purchased bulk vita-
mins at lower prices either directly from U.S. sellers or from arbitra-
geurs selling vitamins imported from the United States, thereby pre-
venting the [defendants] from selling abroad at inflated prices. Thus, 
the super-competitive pricing in the United Sates “gives rise to” the 
foreign super-competitive prices from which the [plaintiffs] claim in-
jury.177 
In what has come to be known as Empagran II,178 the D.C. Circuit, re-
lying on the hints provided by the Supreme Court179 and adopting the 
argument of the government’s amicus brief in the case,180 rejected the 
idea that pleading a single global market181 would be enough to satisfy 
                                                                                                             
the injury to the United States have to be for it to be said that it gave rise to the injury 
overseas?” Goldstein, Perspectives, supra note 33, at 4. 
 177. Empagran S.A. v. F. Hoffman-LaRoche, Ltd. (Empagran II), 417 F.3d 1267, 1270 
(D.C. Cir. 2005). 
 178. Id. 
 179. Edward T. Cavanagh, The FTAIA and Empagran: What Next?, 58 SMU L. REV. 
1419 (2005) [hereinafter Cavanagh, What Next?]. Cavanagh cites the prediction of for-
mer Assistant Attorney General John Shenefield that “the framework for any decision in 
Empagran II had been embedded like the da Vinci Code in Empagran I. Id. at 1433. 
Cavanagh maintained: 
[It would be] implausible that a unanimous Court, after undertaking a detailed 
analysis of the policies underlying the FTAIA and after concluding that juris-
diction was lacking, would have remanded the matter to the circuit court with 
the expectation of a different result. Rather, it is more likely that the Supreme 
Court was simply giving the D.C. Circuit a roadmap to correct its error and 
save face.  
Id. at 1437. 
 180. Makan Delrahim, Drawing the Boundaries of the Sherman Act: Recent Develop-
ments in the Application of the Antitrust Laws to Foreign Conduct, 61 N.Y.U. ANN. 
SURV. AM. L. 415, 426 n.51 (2005). Delrahim, former Deputy Assistant Attorney General 
in the Antitrust Division of the Department of Justice, argued the Division was concerned 
that the plaintiffs’ position presents a “slippery slope” and “no workable method” for 
drawing lines between cases that should be heard in district courts, and those that should 
not. Id. at 427. 
 181. Transcript of Oral Argument at *38, F. Hoffman-La Roche, Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). Stephen M. Shapiro stated: 
[T]he statutes here hinge jurisdiction on commerce. Lawyers can always draw a 
global conspiracy. Economists can always say there’s a global market, and 
these issues would be enormous quagmires for the district courts if that’s what 
our courts’ jurisdiction turned on. Congress did not intend that. It intended a 
clear jurisdictional benchmark by focusing on our commerce . . . and the plain-
834 BROOK. J. INT’L L. [Vol. 31:3 
the FTAIA requirement that the U.S. effects of anti-competitive conduct 
would be enough to give rise to defendants’ claims of foreign injury. 
“Gives rise to,” held the court, “indicates a direct causal relationship, that 
is, proximate causation.”182 
It appears the D.C. Circuit got the Supreme Court’s message on com-
ity: it held that “[t]o read the FTAIA broadly to permit a more flexible, 
less direct standard than proximate cause would open the door to just 
such interference with other nations’ prerogative to safeguard their own 
citizens from anti-competitive activity within their own borders.”183 
B. Other Cases 
Although Empagran II brought some clarity to the issue, the D.C. Cir-
cuit is not, after all, the Supreme Court. Courts in other circuits have 
ruled differently on the issue that the Supreme Court left open.184 Al-
though there seems, since Empagran II, to be a growing consensus that 
proximate causation, and not but-for causation, should be the standard, 
the limit of the Supreme Court’s holding has left room for differing in-
terpretations, and observers note there are still questions to be decided. 
The first case in this line that was decided after Empagran I, Sniado v. 
Bank Austria AG,185 was quickly dismissed by the Second Circuit. The 
case involved allegations that European banks fixed currency exchange 
fees, and the plaintiff, an American citizen, claimed he was injured when 
he exchanged currencies while he was traveling in Europe.186 On remand 
from the Supreme Court, plaintiffs took advantage of the opening left by 
the Empagran I decision, arguing that his injury was not independent of 
the effect on U.S. commerce.187 But the court found that the plaintiff had 
alleged merely a “worldwide conspiracy” (not claiming even a “but-for” 
predicate for his injury), which it found insufficient in light of  
                                                                                                             
tiff before the court has to be alleging treble damages based on that particular 
injury. 
Id. 
 182. Empagran II, 417 F.3d at 1271. But see Hanno Kaiser, The End of the Empagran 
Saga. The D.C. Circuit Rules for the Defendants in Empagran II., ANTITRUST REV.,  Aug. 
2, 2005, http://www.antitrustreview.com/archives/175 (arguing that proximate causation 
is not implied in the claim that “X gave rise to Y.”). 
 183. Empagran II, 417 F.3d at 1271. 
 184. Shenefield, SYMPOSIUM, supra note 34, at 29. 
 185. Sniado v. Bank Austria AG, 378 F.3d 210 (2004). 
 186. Sniado v. Bank Austria AG, 352 F.3d 73, 75–76 (2003). 
 187. Sniado, 378 F.3d at 212. 
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Empagran I; it vacated its prior order and affirmed the lower court’s 
dismissal of the case.188 
In the same month, however, a district court in the Second Circuit re-
fused to dismiss a claim involving distributors of chemical products in 
India.189 The court in MM Global Services had previously found (before 
Empagran I was decided) that alleged resale price-fixing in India had 
resulted in “spillover effects” that inflated prices for the same chemicals 
in the United States.190 Defendants now moved to dismiss on the grounds 
that Empagran I required a foreign plaintiff to show that the effects on 
domestic commerce gave rise to their foreign injuries, while the plaintiffs 
argued that their foreign injuries had an effect on domestic commerce.191 
But the court held it had jurisdiction because the domestic harm and the 
foreign harm were “linked”; it accepted plaintiffs’ view that Empagran I 
was limited to whether the court had jurisdiction over foreign effects that 
are “entirely independent” of domestic effects.192 Here, because the ef-
fects flowed back and forth, they were held to be not entirely independ-
ent.193 
Scholars and practitioners found this holding to be “difficult to harmo-
nise with the result in Sniado”194 and “at odds with the Supreme Court’s 
interpretation” and policy goals.195 But if the Supreme Court had adopted 
a clearer standard, the plaintiffs here would not have been able to exploit 
                                                                                                             
 188. Id. at 213. 
 189. MM Global Services v. Dow Chemical Co., 329 F. Supp. 2d 337 (D. Conn. 2004). 
 190. Mark P. Edwards & Jonathan D. Fischbach, Still Searching for the Meaning of the 
FTAIA: Federal District Court Sustains Sherman Act Claim by Foreign Distributor Suf-
fering Injury in India, MORGAN LEWIS ON COMPETITION, Nov. 2004, at 3, http://www. 
morganlewis.com/index.cfm (follow “Publications,” “Search,” and type “Empagran” into 
“Keyword” field). 
 191. MM Global Services, 329 F. Supp. 2d at 342. See also Cavanagh, What Next?, 
supra note 179, at 1438. 
 192. Cavanagh, What Next?, supra note 179, at 1438. 
 193. MM Global Services, 329 F. Supp. 2d at 342–43. 
 194. Donald C. Klawiter & J. Clayton Everett, Global Cartel Enforcement in 2005: 
Empagran, Executives and Equilibrium, GLOBAL COMPETITION REV. (2005) (on file with 
the Brooklyn Journal of International Law). 
 195. Edwards & Fischbach, supra note 190. They also claim that under the court’s 
theory, “Empagran has preserved subject matter jurisdiction for cases brought by foreign 
firms operating overseas where an ‘effect’ on United States commerce, even an indirect 
and attenuated one, results from foreign anticompetitive conduct.” They argue this is at 
odds with another section of the FTAIA and also runs contrary to a decision in the Ninth 
Circuit, United States v. LSL Biotechnologies, Inc., 379 F.3d 672 (9th Cir. 2004), where 
an agreement between a Mexican and Israeli company concerning the sale of seeds in the 
United States was considered to be too remote to be “direct.” 
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the ambiguity it left open.196 As one observer noted at the time, “If that 
type of allegation is sufficient to survive a motion to dismiss . . . the ex-
ception that the Supreme Court declined to address [whether U.S. courts 
may exercise jurisdiction in cases where foreign injuries are ‘not inde-
pendent’ of effects on U.S. commerce] may end up swallowing the 
rule.”197 
If the Supreme Court intended a proximate cause standard, a decision 
that got it wrong was In re Monosodium Glutamate Antitrust Litiga-
tion,198 where the plaintiffs’ argument was essentially identical to the 
“alternative” argument made in Empagran II that the foreign injury was 
not independent.199 This district court found it did have jurisdiction, just 
a month before the court in Empagran II found the opposite.200 
The court’s holding differed from Empagran II and was even in con-
flict with Empagran I.201 The allegations amounted only to but-for causa-
tion and did not meet the proximate cause standard under  
Empagran II.202 But the court also weighed comity and deterrence differ-
ently from the Supreme Court, finding that, in cases of dependent foreign 
harm, comity is not to be considered and deterrence is of greatest impor-
tance.203 It is difficult to square that view with Empagran I, which held 
that courts should avoid interfering with other nations’ sovereign author-
ity.204 
Since Empagran II, at least three cases have been dismissed at the dis-
trict court level, two on the theory that but-for causation is not sufficient 
(eMag Solutions v. Toda Kogyo Corp.,205 in the Northern District of Cali-
fornia, and Latino Quimica-Amtex v. Akzo Nobel Chemicals,206 in the 
Southern District of New York) and one for lack of direct effect (CSR 
Limited v. Cigna Corp.,207 in the District of New Jersey). The Empagran 
                                                                                                             
 196. Edwards & Fischbach, supra note 190. 
 197. Klawiter & Everett, supra note 194. 
 198. In re Monosodium Glutamate Antitrust Litigation, 2005 WL 1080790 (D. Minn. 
2005). 
 199. Cavanagh, What Next?, supra note 179, at 1438. 
 200. In re Monosodium Glutamate, 2005 WL 1080790. 
 201. Cavanagh, What Next?, supra note 179, at 1439. 
 202. Id. 
 203. Hanno Kaiser, After Empagran: In re Monosodium Glutamate Antitrust Litiga-
tion, ANTITRUST REV., http://www.antitrustreview.com/archives/45 (May 27, 2005). 
 204. Cavanagh, What Next?, supra note 179, at 1439. 
 205. eMag Solutions v. Toda Kogyo Corp., 2005 WL 1712084, at *6 (N.D. Cal. 2005) 
(slip copy). 
 206. Latino Quimica-Amtex v. Akzo Nobel Chemicals, 2005 WL 2207017, at *9 
(S.D.N.Y. 2005) (slip copy). 
 207. CSR Ltd. v. Cigna Corp., 2005 WL 3479908, at *20 (D.N.J. 2005). 
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saga itself finally ended in January 2006 when the Supreme Court denied 
a writ for certiorari from the Empagran plaintiffs.208 
 
Timeline of Cases Applying FTAIA 
 
DATE CASE COURT DISPOSITION 
June 2004 Empagran I Supreme Court Remanded 
Aug. 2004 Sniado 2d Circuit Dismissed 
Aug. 2004 LSL Biotech-
nologies 
9th Circuit Dismissed 
Aug. 2004 MM Global 
Services 




Aug. 2004 UCAR 3d Circuit Remanded 
May 2005 Monosodium 
Glutamate 




June 2005 Empagran II D.C. Circuit Dismissed 
July 2005 eMag Northern District 
of California 
Dismissed 
Sept. 2005 Latino 
Quimica-Amtex
Southern District 
of New York 
Dismissed 




Many commentators believe that the current confusion is rooted in the 
Supreme Court’s approach to the case. By ignoring the allegations in the 
Empagran complaint, and deciding merely a hypothetical case,209 the 
Court left the real issues to the lower courts.210 Practitioners argue that 
the decision and its progeny will cause “uncertainty [that] could be per-
                                                                                                             
 208. Empagran S.A. v. F. Hoffman-La Roche Ltd., 126 S. Ct. 1043 (Mem.) (2006).  
 209. Duke Law, supra note 23. 
 210. See Christopher Sprigman, Fix Prices Globally, Get Sued Locally? U.S. Jurisdic-
tion Over International Cartels, 72 U. CHI. L. REV. 265, 266 (2005); Davis, supra note 
132, at 58, 63–64. The Empagran I Court has even been criticized on its inability to ad-
dress such private law issues. See E. Thomas Sullivan & Robert B. Thompson, The Su-
preme Court and Private Law: The Vanishing Importance of Securities and Antitrust, 53 
EMORY L.J. 1571, 1573–74 (2004) (“The securities and antitrust cases that are taken and 
decided [in the years since Justice Powell’s retirement] are less important and the deci-
sions seem less coherent than in the earlier period [between the time Justices Powell and 
Rehnquist joined the court in 1972 until Powell’s retirement]. This is a Court whose 
members had little in the way of experience with private law before arriving at the high 
court.”). 
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petuated for many years, thereby compounding the chilling effect that 
U.S. antitrust laws may have on foreign business transactions occurring 
wholly outside the U.S.”211 The stability of private markets and public 
confidence in those markets hinge on businesses being able to depend on 
clear standards.212 Because Empagran I did not provide guidelines, it is 
argued, the uncertainty that existed before the decision remains, and 
cases will continue to have high settlement value because “the question 
of whether foreign injury is ‘inextricably intertwined’ with domestic in-
jury will require a detailed factual inquiry.”213 
While the Second Circuit made it clear in Sniado that alleging a 
worldwide conspiracy is not enough to survive a motion to dismiss for 
lack of subject matter jurisdiction,214 and the D.C. Circuit now requires 
proximate causation, scholars, practitioners, and businesspeople are still 
troubled. Their concern is reflected in comments submitted to the U.S. 
Antitrust Modernization Commission by the International Chamber of 
Commerce, which noted that although the D.C. Circuit Court has re-
jected the but-for approach, “there can be no assurance that such an ap-
proach would not be embraced by another appellate court or by a district 
court.”215 
The Supreme Court’s decision has also been criticized for its failure to 
properly distinguish between “effect” and “conduct.”216 Professor Elea-
nor Fox argues that “harm is never caused proximately from the U.S. 
effect,” but rather, by the conduct that is barred by the Sherman Act.217 
She says that the Supreme Court’s approach will lead to under-
deterrence.218 The focus on effect also ignores the element of intent.219 
                                                                                                             
 211. International Chamber of Commerce, Comments on Selected Issues for Study by 
the U.S. Antitrust Modernization Commission, § 3.5 (Sept. 25, 2005), available at 
http://www.amc.gov/public_studies.htm (follow “International” hyperlink). 
 212. Sullivan & Thompson, supra note 210. 
 213. Edward D. Cavanagh, Empagran: A Post Script, ANTITRUST PRACTITIONER, Dec. 
2004, at 6 [hereinafter Cavanagh, Post Script]. 
 214. Klawiter & Everett, supra note 194. See also John H. Shenefield, Jonathan M. 
Rich & J. Clayton Everett, Second Circuit Construes FTAIA in Dismissing Claims 
Against Bank Austria, MORGAN LEWIS ON COMPETITION, Oct. 2004, at 1, 2, http://www. 
morganlewis.com/index.cfm (follow “Publications,” “Search,” and type “Empagran” into 
“Keyword” field) (“The Second Circuit’s decision in Sniado provides little guidance 
about what degree of ‘interdependence,’ if any, is sufficient to establish a predicate for 
subject matter jurisdiction. It does make clear, however, that alleging a ‘worldwide con-
spiracy,’ without more, is insufficient.”). 
 215. International Chamber of Commerce, supra note 211, § 3.3. 
 216. Fox, Testimony, supra note 66, § IV. 
 217.  Id. § IV. 
 218. Id. § IV. 
 219. 1 NANDA & PANSIUS, supra note 5. 
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In the meantime, even legislative action has overtaken Empagran, ar-
guably shifting the balance of the original argument. Only weeks after 
the Empagran Supreme Court decision, Congress passed the Antitrust 
Criminal Penalty Enhancement and Reform Act,220 which reduces treble 
damages in civil litigation to actual damages for antitrust conspirators 
who cooperate with the government.221 The new law also increases 
criminal fines and maximum jail terms. A former Deputy Assistant At-
torney General in the Department of Justice’s Antitrust Division wel-
comed the new law as evidence that Congress “understands how the 
prospect of massive civil liability can deter violators from seeking am-
nesty,”222 and in that light would seem to be aligned with the Empagran 
Court’s decision not to further extend liability. But the Court did not de-
termine whether that liability helped or hurt deterrence. It could be ar-
gued that an Empagran decision that allowed foreign claims would in-
crease deterrence under the new law.223 
It is also strange that Empagran I was inconsistent with other decisions 
this term that narrowed extraterritoriality,224 and especially with its deci-
sion in Intel v. Advanced Micro Devices,225 where the Court not only 
                                                                                                             
 220. Antitrust Criminal Penalty Enhancement and Reform Act, Pub. L. No. 108-237, 
§§ 201–21, 118 Stat. 661, 665–69 (2004). 
 221. Daniel J. Bennett, Note, Killing One Bird With Two Stones: The Effect of Empa-
gran and the Antitrust Criminal Penalty Enhancement and Reform Act of 2004 on Detect-
ing and Deterring International Cartels, 93 GEO. L.J. 1421, 1451–52 (2005). 
 222. Delrahim, supra note 180, at 424. 
 223. Bennett, supra note 221, at 1453–54 (“An increase in potential civil liability for 
those who violate the Sherman Act might [if Empagran had been decided to extend juris-
diction to foreign plaintiffs] thus increase the incentives to participate in the amnesty 
program, and thus increase deterrence of anticompetitive conduct.”). 
 224. Franklin, Perspectives, supra note 158, at 7 (citing four other cases involving 
extraterritoriality, and referring to Empagran as an “outlier,” in the sense that in all the 
others, the court held that U.S. jurisdiction could extend more broadly). See also Swaine, 
Perspectives, supra note 159 (saying the decision “endorsed—without explanation—an 
approach to international comity that was facially inconsistent with the majority opinion 
in Hartford Fire . . . , and even with this Term’s decision in Intel . . . ” and will likely 
“defeat the objectives the Court identified: namely, reassuring foreign nations that their 
sovereign interests (in reducing antitrust enforcement, at least) will be respected, and 
clarifying for wrongdoers their potential liability (by reducing that potential liability, as it 
happens) and thus facilitating the Justice Department’s amnesty program.”) (emphasis in 
original). 
 225. Intel v. Advanced Micro Devices, 542 U.S. 241 (2004). See Franklin, Perspec-
tives, supra note 158, at 7 (arguing that Intel is inconsistent with Empagran, and pointing 
out that while Justice Breyer wrote the majority opinion in Empagran, he dissented in 
Intel). 
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broadened the reach of U.S. law, but did so in that case over the objec-
tion of European Commission officials.226 
Did the Empagran Court give too much deference to the interests of 
foreign nations? One measure of that deference is the decision’s refer-
ences to foreign nations’ amici briefs.227 Said one practitioner, 
That the Court ultimately used comity as the principal basis for a quali-
fied victory for defendants is evidence of the influence of the amici, in-
cluding the governments of Germany, Canada, the United Kingdom, 
Japan, and others, along with international businesses and organiza-
tions. They joined in a chorus of outrage over the American system of 
treble damages, class actions, joint and several liability rules, and the 
like—all of which, the amici pointed out, threatened to make the United 
States the forum of choice for plaintiffs around the world, and thereby 
to upset different legal balances struck in foreign jurisdictions.228  
Fox goes further: “[T]he interests expressed in nations’ amici briefs were 
either simply nationalistic (Japan wanted to protect the coffers of the 
Japanese conspirators) or speculative.”229 
And is this issue actually about subject matter jurisdiction at all? 
Strangely enough, in a case that is generally discussed as being about 
subject matter jurisdiction, Justice Breyer used the term only once, and 
that was in quoting a treatise.230 In avoiding use of the term, he may have 
been signaling that the Court does not believe that that FTAIA is about 
subject matter jurisdiction, and that a plaintiff who pleads a wholly inde-
pendent foreign injury does not state a claim under the Sherman Act as a 
substantive matter.231 The practical significance of the distinction con-
                                                                                                             
 226. Greve & Epstein, supra note 93 (arguing that the Supreme Court’s decision in 
Intel only a week later suggests that Empagran’s promise of comity may prove empty—
that decision broadly construed a federal comity provision regarding discovery requests, 
over the objection of the European Commission). 
 227. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 155, 167–
68 (2004). 
 228. Davis, supra note 132, at 59–60. 
 229. Fox, Remedies, supra note 86, at 581 (referring to Japan’s brief, which noted that 
“a worldwide foreign plaintiff class could seek damages of scores of billions of dollars 
from just two or three Japanese defendants . . . [putting] Japanese firms at a serious com-
petition disadvantage with other firms in that industry.” Brief of the Government of Japan 
as Amicus Curiae in Support of Petitioners at 10, Empagran I, 542 U.S. 155 (No. 03-
724)). 
 230. Empagran I, 542 U.S. at 166. 
 231. E-mail from Elinor Hoffman, Adjunct Associate Professor of Law, Brooklyn Law 
School (Mar. 22, 2006, 5:59 P.M. EST) (on file with author); 1 SPENCER WEBER 
WALLER, ANTITRUST & AMERICAN BUSINESS ABROAD § 9:7B (3d ed. 2005) [hereinafter 
WALLER, ANTITRUST ABROAD] (“[T]he Court did not specifically discuss the lingering 
question of whether proof of the requisite effects on the U.S. market were jurisdictional 
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cerns the burden of proof and the level of review: if it is jurisdictional, 
the action is a dismissal—the burden is on the plaintiff and an appeals 
court should defer to the district court; if it is an element of the claim, 
then the action is a motion for summary judgment—the burden is on de-
fendant, and the appeals court may review de novo.232 
What happens next? Some have said that because Empagran I was de-
cided so narrowly, and neglected to address the more likely factual situa-
tions (indeed, perhaps all fact patterns, as it remains to be seen whether 
the hypothetical situation it did decide will ever occur), lower courts will 
disagree on how to apply its rule and another circuit split is inevitable.233 
Writing in December 2005, Professor Spencer Weber Waller predicted, 
“Years of additional litigation or statutory change will be necessary to 
definitively resolve this critical question [whether foreign antitrust plain-
tiffs suffering injury abroad can bring their claims to U.S. courts]. The 
split in the circuits and the importance of the issue strongly suggests that 
the Supreme Court will accept a petition for certiorari in the near future 
in order to resolve this point.”234 
VII. ALTERNATIVES TO THE EMPAGRAN APPROACH 
After Empagran, there is still a vigorous debate among antitrust schol-
ars about how domestic laws should accommodate global trade. On one 
side are those who believe that competition authorities should set their 
own standards and continue to work together informally; on the other are 
those who believe international competition authorities should adopt one 
standard for the world.235 
Professor Harry First is one of the proponents of expanding the extra-
territoriality of national law along with adoption of bilateral enforcement 
cooperation agreements; he believes that new structures are not neces-
sary because “a system of international competition law is already evolv-
ing, even without the formal adoption of legal principles and without the 
establishment of any new enforcement mechanism.”236 This system, he 
                                                                                                             
or substantive in nature, but the thrust of the Court’s opinion suggests that the Justices 
view the issue as a substantive element of the offense.”). 
 232. 1 NANDA & PANSIUS, supra note 5 (arguing that this issue has been “largely ig-
nored” by the courts and that, although the FTAIA has been viewed as jurisdictional, “in 
practice most Circuit Courts have not been unwilling to assert their review powers”). 
 233. Cavanagh, Post Script, supra note 213, at 7. 
 234. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 13:23. 
 235. See Spencer Weber Waller, The Internationalization of Antitrust Enforcement, 77 
B.U. L. REV. 343, 345–47 (2002) (describing the range of views on the subject). 
 236. First, Vitamins, supra note 12, at 712. See also Shenefield, Coherence, supra note 
38, at 430 (noting that Sir Leon Brittan’s conclusion in 1992 was that “the only remedy 
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says, based on consensus and virtually unilateral enforcement, has cre-
ated a de facto international competition law.237 
But Professor Diane Wood has pointed out that the growing consensus 
that “national boundaries are of little if any relevance to the anticompeti-
tive behavior of multinational enterprises” that led to the increasing use 
of independent extraterritorial jurisdiction around the world has ironi-
cally produced the very result it was intended to avoid—interdepend-
ence.238 There may be no way to make a distinction between foreign and 
domestic commerce “in a world where U.S. tax returns are prepared in 
India.”239 If the Empagran holding requires a “double effects test,” that 
is, a sufficiently adverse effect within the United States, and a U.S. effect 
that affects the foreign effect, then worldwide interdependence will ulti-
mately make the test meaningless: if it is strictly applied, no foreign 
plaintiffs will be able to meet the test, and if it is loosely applied it could 
encompass virtually any case.240 This supports Professor Wood’s view 
that the wider application of extraterritorial jurisdiction leads to a greater 
need for international agreements.241 
                                                                                                             
available today is antitrust enforcement by the country in which the private conduct is 
taking place; other antitrust enforcement would be viewed as excessively extraterrito-
rial.”). 
 237. First, Vitamins, supra note 12, at 727. But others have noted that the practical 
effect of cooperation agreements has been limited. Shenefield, Coherence, supra note 38, 
at 394. Eleanor Fox points out a reason: cooperation will work “only if the two jurisdic-
tions see eye-to-eye on the anticompetitiveness of the restraint and the importance of the 
enforcement given other priorities.” Eleanor M. Fox, International Antitrust and the 
Doha Dome, 43 VA. J. INT’L L. 911, 921 (2003) [hereinafter Fox, Doha Dome]. Edward 
Hand observed in a 2003 paper that “since 1991 we have made only one formal positive 
comity referral to the EU.” Edward T. Hand, Department of Justice Experience in Recon-
ciling Antitrust and Trade, 47 N.Y.L. SCH. L. REV. 131, 135 (2003). 
 238. Wood, supra note 40, at 301–03 (pointing out the irony in that agreements on 
extraterritorial jurisdiction have given birth to new problems, which are pushing us back 
toward the model of international agreements on competition). 
 239. 1 NANDA & PANSIUS, supra note 5. 
 240. Id. § 8:13. 
 241. Wood, supra note 40, at 301. See also Shenefield, Coherence, supra note 38, at 
388–89 (2004) for an overview of early attempts by the United States and international 
bodies to foster the development of antitrust law abroad. Shenefield states: 
[A] goal of perfect convergence—coming to the same substantive point from 
different directions—is an illusion. It can never happen; it will never happen; 
and even if it could happen, it would in all probability be a bad thing. There are 
too many variations of country and culture to permit a uniform formulation of 
the law of competition to be successful everywhere and for all times.  
Id. The opposite approach, however—each nation going its own way—results in “costly 
international enforcement chaos.” Id. at 389. 
2006] THE FTAIA AND EXTRATERRITORIAL EFFECTS 843 
The international model, or “one-standard” view, is advocated by, 
among others, Professor Fox.242 Antitrust authorities around the world 
have already taken steps in that direction: by creating a horizontal net-
work of antitrust agencies (the International Competition Network, or 
ICN243) and by forming a World Trade Organization Working Group on 
the Interaction Between Trade and Competition Policy, although little 
action on that front has been taken to date.244 
Perhaps comity no longer makes sense in a globalized economy.245 Fox 
argues that the comity doctrine works only on the “nation-to-nation 
level,” and does not take into consideration global concerns as proposed 
international antitrust models.246 Professor Waller maintains, in an article 
titled “The Twilight of Comity,” that more practical litigation matters 
(such as service of process, venue, personal jurisdiction, discovery, ap-
pellate review, and enforcement of judgments) restrain plaintiffs from 
suing, so that extraterritoriality and comity may no longer be of such 
great importance.247 This section considers other methods to achieve the 
Supreme Court’s goal in Empagran: to limit interference with other na-
tions’ antitrust policies without harming global antitrust enforcement. 
A. Reforming the FTAIA 
It would be easy to conclude that the easiest way out of the muddle 
would be for Congress to rewrite the FTAIA. Given how badly written 
the statute is, it should be a good candidate for reform. In fact, the Anti-
trust Modernization Commission is studying this issue (among others) 
                                                                                                             
 242. See generally Fox, Doha Dome, supra note 237, at 911–12. 
 243. See International Competition Network Home Page, http://www.international 
competitionnetwork.org (last visited Mar. 5, 2006); see also Fox, Testimony, supra note 
66, § I. 
 244. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 18:11; Fox, Doha Dome, su-
pra note 237, at 911–12; see generally Friedl Weiss, From World Trade Law to World 
Competition Law, 23 FORDHAM INT’L L.J. 250 (2000). For a thorough analysis of the 
argument against putting antitrust enforcement within the WTO, see Shenefield, Coher-
ence, supra note 38, at 430–32. For the opposing view, see Fox, Doha Dome, supra note 
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and will make a recommendation to the President and Congress.248 But 
experts differ on whether Congress should take on the task. 
Many organizations representing business interests prefer a legislative 
approach, which they feel would provide the most certainty with regard 
to business transactions occurring entirely abroad.249 The International 
Commerce Commission is one such organization; it takes the view that 
Congress “is in the best position” to address the issue.250 Another is the 
Chamber of Commerce of the United States, which suggests that Con-
gress codify the D.C. Circuit’s proximate cause standard;251 the Business 
Roundtable agrees, suggesting that if other courts diverge from the D.C. 
Circuit’s approach, Congress should codify it.252 The International Bar 
Association takes the same position, arguing that legislative action would 
provide legal certainty, that Congress is in the best position to consider 
policy implications of the extraterritorial effect of U.S. law, and that leg-
islation would be faster than common law development.253 
On the other hand, the American Bar Association believes the statute is 
best left as it is, and that the courts are “best suited” to deal with the is-
sues left by Empagran I.254 Among its reasons is that causation standards 
are best developed in the courts; that Congress has generally left the set-
ting of such standards to judicial interpretation, and that development of 
a post-Empagran jurisprudence would best be handled through the real-
world circumstances of actual cases.255 This view has support in the tes-
                                                                                                             
 248. Shenefield, SYMPOSIUM, supra note 34. 
 249. International Chamber of Commerce, supra note 211. 
 250. Id. § 3.6. 
 251. Chamber of Commerce of the United States of America, Comments on Commis-
sion Issues Accepted for Study, § 4 (Nov. 8, 2005), available at http://www.amc.gov/ 
public_studies.htm (follow “International” hyperlink). 
 252. Comments of the Business Roundtable Regarding the Issues Selected for Study by 
the Antitrust Modernization Commission, Antitrust Modernization Commission, § 6(B) 
(Nov. 4, 2005), available at http://www.amc.gov/public_studies.htm (follow “Interna-
tional” hyperlink). 
 253. International Bar Association, Submission to the US Antitrust Modernization 
Committee, at 13–15, 16 (Jan. 27, 2006), available at http://www.amc.gov/public_ 
studies.htm (follow “International” hyperlink). 
 254. American Bar Association, Antitrust Section, Submission to the Antitrust Mod-
ernization Commission Concerning Whether Congress Should Amend the FTAIA to Clar-
ify the Circumstances in Which the Sherman Act Applies to Extraterritorial Anticompeti-
tive Conduct, § VII  (Feb. 8, 2006), available at http://www.amc.gov/public_studies.htm 
(follow “International” hyperlink).  
 255. Id. § VI (B) (2),(3) (arguing that, if the Antitrust Modernization Commission does 
recommend that Congress revise the FTAIA, the language “should reflect clear, bright-
line standards that simplify the analysis and provide the courts and public with practical 
guidance.” Id. at § VII.). 
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timony of James Atwood, who argues that “legislative initiatives do not 
always solve the problems they set out to address,” a view that perhaps 
has no greater support than in the experience of the FTAIA itself;256 and 
Randolf Tritell, Assistant Director for International Antitrust at the Fed-
eral Trade Commission, who testified that, in light of recent decisions, 
“there does not appear to be a need to seek legislative clarification at this 
time.”257 
Congressional consideration of the FTAIA could, however, open up a 
can of worms—the original purpose of the FTAIA in protecting U.S. ex-
port cartels may not play well on the foreign trade relations front. As 
Professor Fox asks, “Can we legitimately embrace jurisdiction when our 
ox is gored but disclaim jurisdiction when our ox is goring?”258 She takes 
the view that export cartel exceptions should be abolished,259 and pro-
poses repealing the FTAIA and substituting a simple provision in its 
place: “The Sherman and FTC Acts shall not apply to harms not within 
the United States and not on U.S. territory.”260 
B. Standing 
It is curious that the issue at the heart of Empagran has been addressed 
only through the lens of subject matter jurisdiction and not through 
standing.261 The circuit court in Empagran found that the plaintiffs had 
antitrust standing,262 and the Supreme Court avoided the issue entirely,263 
saying that “[t]he question of who can or cannot sue is a matter for other 
                                                                                                             
 256. James R. Atwood, Testimony before the Antitrust Modernization Commission, 
Hearings on International Issues, § 5 (Feb. 15, 2006), http://www.amc.gov/commision_ 
hearings/international_antitrust.htm. 
 257. Randolf W. Tritell, Testimony before the Antitrust Modernization Commission, 
Hearings on International Issues, § I (Feb. 15, 2006), http://www.amc.gov/commision_ 
hearings/international_antitrust.htm. 
 258. Fox, Testimony, supra note 66, § V. 
 259. Id. 
 260. Id. § IV (suggesting the Webb-Pomerene Act and Export Trading Certificate of 
Review Act should also be repealed). For a discussion of the WPA and ETC, see Marga-
ret C. Levenstein & Valerie Y. Suslow, The Changing International Status of Export 
Cartel Exemptions, 20 AM. U. INT’L L. REV. 785, 789–804 (2005). 
 261. Cavanagh, SYMPOSIUM, supra note 151, at 25 (“I think all these cases could be 
decided on standing.”). 
 262. Empagran S.A. v. F. Hoffman-La Roche, Ltd., 315 F.3d 338, 357 (D.C. Cir. 
2003). 
 263. Cavanagh, What Next?, supra note 179, at 1440. Cavanagh believes the Circuit 
Court’s reasoning was overruled by the Supreme Court in Empagran I, even though the 
Supreme Court did not reach the standing issue because it overturned the Circuit Court’s 
decision on other grounds. Id. at 1445. 
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statutes (namely, the Clayton Act) to determine.”264 Decisions on foreign 
purchasers’ standing in other courts are “sparse,”265 but at least two 
courts have rejected standing for foreign purchasers266 and one of those 
held that participation in the U.S. market is “crucial” to establishing anti-
trust standing.267 Yet one of the issues of importance to the Supreme 
Court—judicial administration—could be addressed more easily through 
standing.268 
To establish antitrust standing, a threshold question that is separate 
from the question of subject matter jurisdiction,269 a plaintiff must over-
come three limitations.270 First, he must meet constitutional requirements 
of standing under the Clayton Act271 by establishing “injury-in-fact or 
threatened injury-in-fact caused by the defendant’s alleged wrongdo-
ing.272 Second, he must establish “antitrust injury” by showing that the 
injury suffered is “of the type the antitrust laws were intended to prevent 
and that flows from that which makes the defendants’ acts unlawful.”273 
This establishes that the plaintiff’s injury is not just any injury, but an 
injury made illegal by the Sherman Act. Finally, a plaintiff must be a 
“proper plaintiff” according to a set of factors known as the Associated 
General Contractors274 factors: these include “the proximity (‘remote-
ness’) of the causal connection between the defendant’s antitrust viola-
tion and the plaintiff’s harm, evidence of an actual intent to cause that 
harm, whether there are more direct victims, the speculativeness of the 
plaintiff’s claimed injury, and the potential for duplicative recovery or 
                                                                                                             
 264. F. Hoffman-La Roche Ltd. v. Empagran S.A. (Empagran I), 542 U.S. 155, 173 
(2004). 
 265. Cavanagh, What Next?, supra note 179, at 1440. 
 266. Id. at 1446 (referring to Galavan Supplements, Ltd. v. Archer Daniels Midland 
Co., 1997 WL 732498 (N.D. Cal. 1997) and In re Microsoft Corp. Litig., 127 F. Supp. 2d 
702, 715 (D. Md. 2001)). 
 267. Cavanagh, What Next?, supra note 179, at 1447 (referring to In re Microsoft, 127 
F. Supp. 2d at 715). 
 268. Comment, Federal Statutes and Regulations, Foreign Trade Antitrust Improve-
ment Act, 118 HARV. L. REV. 476, 483–84 (2004). 
 269. Cavanagh, What Next?, supra note 179, at 1440. For a detailed analysis of this 
issue, see id. 1440–51. 
 270. WILLIAM C. HOLMES, ANTITRUST LAW HANDBOOK § 1:9 (2004) [hereinafter 
HOLMES, HANDBOOK]. 
 271. Clayton Act, 15 U.S.C. §§ 12–27 (1914). 
 272. HOLMES, HANDBOOK, supra note 270 (citing Andrx Pharms., Inc. v. Biovail Corp. 
Int’l, 256 F. 3d 799 (D.C. Cir. 2001)). 
 273. William C. Holmes, Jurisdiction and Standing in the International Arena, 14 
LOY. CONSUMER L. REV. 537, 544 (2002) [hereinafter Holmes, Jurisdiction] (citing 
Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc., 429 U.S. 477, 489 (1977)). 
 274. Associated General Contractors, 459 U.S. at 538–44 (1983). 
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overly complex apportionment of damages.”275 Simply put, application 
of standing requirements limits antitrust claims “to those who are in the 
best position to prosecute the claim and bars those claims arising from a 
ripple effect.”276 
One of the merits of approaching the issue through standing is that the 
concerns that underpin standing analysis parallel, in some respects, the 
policies that inform decisions on subject matter jurisdiction.277 Both ad-
dress judicial efficiency, detection, and deterrence.278 And the test for 
standing is proximate cause,279 now arguably the predicate for subject 
matter jurisdiction. Using standing doctrine, a court’s view on subject 
matter jurisdiction, whether narrow or broad, would not matter as 
greatly. 
Professor Cavanagh believes that foreign plaintiffs would face “formi-
dable hurdle[s]” to establishing standing if the standard were applied 
properly.280 Resolution of foreign claims under the standing doctrine 
would be easier than applying the FTAIA, he says.281 Using standing 
analysis would be “more logical”282 and avoid the “strange and strained 
construction of the FTAIA” that the Supreme Court set out in Empa-
gran.283 In fact, Cavanagh argues, the Supreme Court should have de-
cided the standing issue in Empagran.284 
Perhaps the criticisms of the Supreme Court’s decision and the ramifi-
cations of the continuing development of the jurisdictional issues in 
                                                                                                             
 275. Holmes, Jurisdiction, supra note 273. 
 276. Edward D. Cavanagh, Antitrust in the Second Circuit, 65 ST. JOHN’S L. REV. 795, 
810 (1991). 
 277. Davis, supra note 132, at 63 (pointing out that “the issues in Empagran have 
much in common with the issues in Illinois Brick,” the leading case on the standard for 
standing). 
 278. Id. at 63 (“Just as Illinois Brick balanced judicial efficiency, deterrence of viola-
tions, and other relevant factors to establish an extra-statutory rule as to who may sue and 
who may not, so also the Empagran scenario demands a careful analysis and balancing of 
judicial efficiency, cartel detection, and cartel deterrence.”). 
 279. Cavanagh, What Next?, supra note 179, at 1448. 
 280. Cavanagh, Post Script, supra note 213, at 7. 
 281. Cavanagh, What Next?, supra note 179, at 1431. 
 282. Holmes, Jurisdiction, supra note 273, at 546. 
 283. Fox, Testimony, supra note 66, § IV. See also Holmes, Jurisdiction, supra note 
273, at 537 (“Rather than address the issue as one of standing, the courts have articulated 
an exceedingly intricate jurisdictional analysis under the [FTAIA] that few can hope to 
truly understand and that arguably does harm to both the statutory language of the Act 
and its legislative history.”). 
 284. Cavanagh, What Next?, supra note 179, at 1431. 
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lower courts will bring more attention to the issue of standing in foreign 
plaintiff antitrust litigation.285 
C. Forum Non Conveniens 
The real question should be this: should foreign antitrust plaintiffs be 
allowed to use U.S. courts to sue foreign defendants when the transac-
tions occurred entirely outside the United States, when the behavior has 
already been discovered and the U.S. government has successfully con-
cluded a criminal action, and when U.S. plaintiffs have separately pur-
sued, or are pursuing, their own claims? In such cases, it would appear 
that all U.S. interests have been dealt with. The Vitamins cartel members 
acted on the international stage; now that so many countries have anti-
trust regimes, one might well ask why all claims against these actors 
should be litigated in the United States. If a means can be found to en-
sure that there is a venue in foreign courts in which to litigate such 
claims dismissed from U.S. courts, two of the policy concerns at issue—
burden on the courts and impact on development of antitrust regimes—
would be resolved, and overall deterrence would be only marginally re-
duced.286 
A doctrine that has been used only infrequently in transnational anti-
trust litigation, but which may see renewed interest since Empagran (es-
pecially since the Supreme Court raised it in oral argument) is forum non 
conveniens.287 Waller believes the doctrine “holds considerable promise 
for use in foreign commerce antitrust litigation.”288 Forum non conven-
iens permits a court to abstain from the exercise of jurisdiction on the 
motion of a defendant when the forum chosen by the plaintiff is unjust to 
the defendant, and where a more convenient forum exists to hear the dis-
pute.289 This common law doctrine, established in Gulf Oil Corp. v. Gil-
                                                                                                             
 285. Cavanagh, Post Script, supra note 213. 
 286. See Buxbaum, supra note 149, at 373 (arguing that the policy goal of deterrence 
could be satisfied through public regulation with a high level of aggregate fines imposed 
by the United States and other countries, rather than through private enforcement). 
 287. Transcript of Oral Argument at *29, F. Hoffman-La Roche, Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). 
 288. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27 (“The use of forum non 
conveniens would mean that litigation of jurisdictional questions would shift from the all 
or nothing proposition of whether the United States has jurisdiction to whether the U.S. is 
the best forum for resolution of the dispute.”) (emphasis in original). See also 1 WALLER, 
ANTITRUST ABROAD, supra note 231, § 6:17 (arguing that forum non conveniens provides 
a powerful addition, if not a substitute, for disputes over jurisdiction and comity in ap-
propriate transnational antitrust cases). 
 289. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27. Notice that jurisdiction 
is assumed. See Sandage, supra note 75, at 1707–08 (“The defendant’s objection in such 
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bert290 and developed in Piper Aircraft Co. v. Reyno,291 requires a court 
to consider the presence of a suitable forum in another country, the plain-
tiff’s nationality, the relevance of what nation’s law would control the 
case, and a balance of “public” and “private” factors.292 
Using forum non conveniens to decline hearing cases that have a closer 
connection with another country has the virtue of encompassing comity 
values, because it similarly addresses respect for the interests of the for-
eign sovereign.293 In addition, because the availability of another forum 
to hear the dispute is a factor in considering dismissal under forum non 
                                                                                                             
a motion is typically not a challenge to the subject matter jurisdiction of the court per se, 
but rather an assertion of the impropriety of that particular court’s exercising its jurisdic-
tion over the case because litigation in such an inconvenient forum amounts to an ille-
gitimate exercise of state power.”). 
 290. Gulf Oil Corp. v. Gilbert, 330 U.S. 501 (1947). 
 291. Piper Aircraft Co. v. Reyno, 454 U.S. 235 (1981). 
 292. William L. Reynolds, The Proper Forum for a Suit: Transnational Forum Non 
Conveniens and Counter-Suit Injunctions in the Federal Courts, 70 TEX. L. REV. 1663, 
1666 (1992). 
 293. Mladen Don Kresic, Note, The Inconvenient Forum and International Comity in 
Private Antitrust Actions, 52 FORDHAM L. REV. 399, 418 (1983).  According to Kresic: 
[C]omity analysis stresses national concerns and ignores the litigants’ interests. 
Forum non conveniens, however, encompasses the requirement of comity 
within the framework of existing law. All factors used in balancing public or 
national interests involved in an antitrust action under Timberlane can be ade-
quately weighed in a public interest analysis under forum non conveniens          
. . . . The opportunity given to defendants to present all national interest factors 
favoring dismissal under the public interest consideration of forum non conven-
iens should help reduce tensions caused by extraterritorial extension of the anti-
trust laws . . . . The strong public interest in American antitrust enforcement 
should also play a major role in the forum non conveniens analysis. Thus, the 
interest that a foreign state has in the litigation must outweigh the effects that 
the alleged antitrust violations have in the United States . . . . [I]f there is an 
anticompetitive effect in the United States, but it is outweighed by the effect in 
a foreign nation, then the suit may be dismissed in favor of an action brought in 
another forum. 
Id. See also Reynolds, supra note 292, at 1714 (“The American courts’ willingness to 
defer to the exercise of foreign jurisdiction not only shows the respect due other sover-
eigns, but is increasingly necessary in an ever-shrinking world.”). Mladen Kresic and 
John Sandage’s arguments against the broader use of comity analysis—because it is too 
complicated for judges and not appropriate for the judicial branch to engage in political 
balancing—show why forum non conveniens is a more appropriate tool in this arena. See 
generally Kresic, supra; Sandage, supra note 75. But see Bates, supra note 46, at 314 
(arguing that using forum non conveniens in this way would stretch the doctrine beyond 
recognition into a diplomatic device). 
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conveniens,294 protections for plaintiffs can be built in:295 a court may 
condition dismissal on defendants’ acceptance of the jurisdiction of the 
foreign court to ensure that the interests of foreign parties and govern-
ments can be addressed without depriving the plaintiff of a remedy.296 
The litigation would then proceed in the foreign court, subject to foreign 
law and procedure.297 For this reason, dismissal for forum non conven-
iens has an advantage over dismissal for lack of subject matter jurisdic-
tion or for reasons of comity: it ensures that the plaintiff gets its day in 
court and that defendants do not escape liability.298 
In weighing the factors for or against dismissal for forum non conven-
iens under Reyno, a difference in the substantive law to be applied is not 
generally given great weight,299 although dismissal will not be granted in 
a case in which the remedy provided by the alternative forum is “so 
                                                                                                             
 294. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27. It may complicate mat-
ters, however, if some of the plaintiffs in an action are from countries that have devel-
oped antitrust regimes and some are from countries that do not. 
 295. Reynolds notes that Reyno specifically endorses some measure of discrimination 
against foreign plaintiffs: “When the home forum has been chosen [by plaintiff], it is 
reasonable to assume that the choice is convenient. When the plaintiff is foreign, how-
ever, this assumption is made less reasonable.” Reynolds, supra note 292, at 1693. 
 296. 1 WALLER, ANTITRUST ABROAD, supra note 231, § 6:17. See also Reynolds, supra 
note 292, at 1666–67 (pointing out that courts “routinely condition dismissal on the de-
fendant’s waiving the foreign limitations period and agreeing to accept service in a for-
eign jurisdiction,” that they may also “condition a dismissal on the defendant’s promise 
to pay any judgment” and that they “should also condition the dismissal on the willing-
ness of the foreign court to hear the case—including third-party claims—a condition that 
assures the availability of the alternative forum.” See also John Fellas, Choice of Forum 
in International Litigation, 704 PLI/LIT 239, 307 (2004) (“If the proponent of dismissal 
fails to comply with the order, the action will be reinstated in the U.S.”). 
 297. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27 (pointing out that there 
must be a meaningful remedy available, but it need not be as generous as that available in 
the United States for forum non conveniens to apply). 
 298. 1 WALLER, ANTITRUST ABROAD, supra note 231, § 6:17 (“The doctrine of forum 
non conveniens has the appealing feature of eliminating the all or nothing aspect of litiga-
tion over jurisdiction to prescribe.”). 
 299. Reynolds, supra note 292, at 1670, quoting Piper Aircraft Co. v. Reyno, 454 U.S. 
235, 247 (1981) (“The possibility of a change in substantive law should ordinarily not be 
given conclusive or even substantial weight in the forum non conveniens inquiry.”). See 
also Erika Nijenhuis, Comment, Antitrust Suits Involving Foreign Commerce: Sugges-
tions for Procedural Reform, 135 U. PA. L. REV. 1003, 1038–39 (1987), citing Mitsubishi 
Motors Corp. v. Soler Chrysler-Plymouth, Inc., 473 U.S. 614 (1985) (in which the Court 
subordinated U.S. interests in antitrust enforcement to an arbitration agreement between 
the parties specifying a Japanese tribunal, even though Japanese antitrust enforcement (at 
the time) was not nearly as robust as in the United States.). 
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clearly inadequate or unsatisfactory that it is no remedy at all,”300 some-
thing that the Empagran Court was concerned with.301 This means there 
must not only be a criminal antitrust statute, but there must be a private 
right of action.302 
Although such rights are not as widely available outside the United 
States, there is now a private right of action in the European Union.303 As 
noted earlier, the number of countries with developed antitrust regimes is 
growing. Certainly the type of case dealt with here—per se price fixing 
violations—is covered by the laws of all countries that have such re-
gimes.304 And although Ecuador and Ukraine, two of the countries from 
which the plaintiffs in Empagran came, may not provide adequate anti-
                                                                                                             
 300. Reynolds, supra note 292, at 1671, quoting Reyno, 454 U.S. at 254. See also Fel-
las, supra note 296, at 284 (pointing out that a Brazilian forum was held to be adequate 
even though Brazil did not permit punitive damages in De Melo v. Lederle Labs., 801 
F.2d 1058 (8th Cir. 1986)). 
 301. Transcript of Oral Argument at *33, F. Hoffman-La Roche, Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). The Court asked if defendants 
were proposing that the Court make a distinction between countries that have antitrust 
laws and those that do not. There is a danger that “[a]n aggressive policy favoring com-
ity-based dismissals might create a two-tiered system, where foreign plaintiffs from de-
veloped antitrust regimes such as the EU, Australia, and Canada are often barred from 
U.S. courts, while plaintiffs from many developing countries are admitted.” Sprigman, 
supra note 210, at 282. See also Reynolds, supra note 292, at 1667–68, for an overview 
of this issue, and Buxbaum, supra note 149, at 374–76, arguing that the doctrine of forum 
non conveniens could solve some of the procedural difficulties, but noting that because 
“dismissal on that basis is permissible only when there is an adequate alternative remedy 
abroad . . . a U.S. court would have no authority to order dismissal of a case involving a 
foreign transaction if the country in question did not permit private rights of action at all.” 
 302. Buxbaum, supra note 149, at 375–76. See also 2 WALLER, ANTITRUST ABROAD, 
supra note 231, § 21:27 (arguing that if dismissal based on forum non conveniens is not 
warranted because a particular jurisdiction does not have a private right of action cover-
ing the subject matter of U.S. antitrust law, “[t]hat is only a reason to deny a motion in a 
particular case . . . and not to deny the applicability of the doctrine in its totality.”). 
 303. See Donncadh Woods, Private Enforcement of Antitrust Rules—Modernization of 
the EU Rules and the Road Ahead, 16 LOY. CONSUMER L. REV. 431 (2004). 
 304. Dorsey D. Ellis, Jr., Projecting the Long Arm of the Law: Extraterritorial Crimi-
nal Enforcement of U.S. Antitrust Laws in the Global Economy, 1 WASH. U. GLOBAL 
STUD. L. REV. 477, 496–97 (2002) (noting that price-fixing agreements are unlawful un-
der every competition law and universally deplored as adversely affecting consumer wel-
fare). See also Reynolds, supra note 292, at 1681 (“The fact that a foreign forum has a 
strong interest in the outcome of the case may support a decision to dismiss an action. 
Often the foreign forum has a strong interest in having its own law applied in its own 
courts.”). 
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trust laws,305 the home countries of some, if not all, of the cartel members 
provide for private damage claims.306 
It may be difficult for district court judges to make determinations 
about the adequacy of foreign antitrust regimes, both due to the complex-
ity of the review and the fact that precedent provides little value for a 
current assessment;307 in addition, such judgments would likely be pro-
tested by foreign countries.308 It has been suggested that the U.S. De-
partment of Justice should annually review foreign countries’ antitrust 
regimes to determine whether they provide adequate relief for private 
parties, and that jurisdiction over cases where both plaintiff and defen-
dant are foreign should be barred in such cases by amending the Clayton 
Act.309 Such a policy would have the benefit of consistency and predict-
ability, and the executive branch is better positioned to assess the politi-
cal tradeoffs,310 although such determinations would probably be even 
more highly resented by foreign governments as an intrusion into their 
own political systems.311 While such a policy would be in keeping with a 
forum non conveniens analysis, it is probably not necessary.312 
Of course, a defendant who moves to dismiss on grounds of forum non 
conveniens generally does so because he wants the case dismissed en-
tirely, not because he would rather have the case heard in another 
                                                                                                             
 305. They may be technically adequate. Wolfgang Wurmnest, Foreign Private Plain-
tiffs, Global Conspiracies, and the Extraterritorial Application of U.S. Antitrust Law, 28 
HASTINGS INT’L & COMPETITION. L. REV. 205, 221–23 (2005) (explaining that both these 
countries have recently enacted antitrust statutes which appear to be “robust” and allow 
for private damages, but it is questionable how adequate they really are). 
 306. Germany is part of the EU; Japan has an antitrust regime. See Fellas, supra note 
296, at 278 (“[M]ost courts have granted motions to dismiss on grounds of forum non 
conveniens notwithstanding the fact that foreign law does not provide the same remedy 
as that available under U.S. law, as long as there is some remedy under foreign law.”) 
(emphasis added). 
 307. Jonathan T. Schmidt, Note, Keeping U.S. Courts Open to Foreign Antitrust Plain-
tiffs: A Hybrid Approach to the Effective Deterrence of International Cartels, 31 YALE J. 
INT’L L. 211, 256 (2006). 
 308. Wurmnest, supra note 305, at 223. 
 309. Schmidt, supra note 307, at 258–59 (suggesting a detailed review that would “dis-
tinguish the types of claims for which a country’s relief is adequate from those for which 
it is inadequate.”). 
 310. Robert Walter Trenchard, The Scope of Antitrust Jurisdiction Abroad: A Classic 
Conflicts-of-Law Problem, at 31 (2004), available at http://ssrn.com/abstract=533462. 
 311. Bates, supra note 46, at 314–15 (arguing that comity is a better approach to the 
issue). 
 312. Fellas, supra note 296, at 284. 
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venue.313 So defendants would be unlikely to make such a motion. (The 
perceived advantages for foreign plaintiffs in U.S. courts, however, such 
as treble damages and liberal enforcement of judgments, may be less ad-
vantageous than they appear at first blush: in many instances the plaintiff 
may only retain single damages or its equivalent anyway, due to foreign 
“claw-back” provisions, the fact that U.S. courts do not grant interest on 
damages as they do elsewhere, and the reduction of the availability of 
treble damages under the new Antitrust Criminal Penalty Enhancement 
and Reform Act.314) However, although forum non conveniens is almost 
always considered on the motion of a party, there does not appear to be a 
bar to the court doing it sua sponte.315 
                                                                                                             
 313. Transcript of Oral Argument at *34–35, F. Hoffman-La Roche, Ltd. v. Empagran 
S.A. (Empagran I), 542 U.S. 155 (2004) (No. 03-724). Plaintiffs’ attorney Thomas C. 
Goldstein stated: 
If there’s some substantial remedy available in another country, then you can 
go somewhere else. But they didn’t file that motion because they’re trying to 
get rid of the case with respect to the majority of bulk vitamins commerce and 
with respect to most of the commerce in these worldwide markets for which 
there is no remedy. 
Id. See 1 WALLER, ANTITRUST ABROAD, supra note 231, § 6:17 (“Defendants often are 
not seeking to litigate in their home courts versus the United States, they more commonly 
seek outright dismissal.”) But there are other reasons a defendant may prefer a foreign 
venue over the United States even if the case cannot be dismissed outright: extensive 
discovery procedures, compulsory process, and treble damages. Reynolds, supra note 
292, at 1673–74. 
 314. See Kresic, supra note 293, at 425 (“[F]oreign statutes, such as the British ‘claw 
back’ provisions, enable defendants to recover the punitive portion of the damages 
awarded in a United States action. Therefore, the remedy available in a foreign forum 
may be no less adequate than the one obtained in an American court.”). Waller also 
points out: 
Plaintiff would also be free from further jurisdictional challenges . . . . If the 
end product is an enforceable judgment for single damages, it is difficult to say 
plaintiff is worse off than if the outcome had been a monumental treble damage 
jury verdict against a defendant with no U.S. assets and little prospect for en-
forcement abroad.  
2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27. The new Antitrust Criminal 
Penalty Enhancement and Reform Act reduces the availability of treble damages for anti-
trust conspirators who cooperate with the U.S. government. See supra note 215. 
 315. Fine v. McGuire, 433 F.2d 499, 501 (D.C. Cir. 1970) (“It is fair to suppose that 
the general contemplation was that transfer under 1404 would be triggered by a motion. 
This is not to say that a district judge may not initiate consideration of the convenience 
factor, but ordinarily at least he will not take action unless a party, and that party can be 
the plaintiff, files an appropriate motion.”) (emphasis added). In the context of enforce-
ment of private forum selection clauses in international contracts, Hannah Buxbaum says 
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Perhaps it is time for the Court to add one or more factors to consider 
in forum non conveniens analysis, including the following: when all the 
defendants and all the plaintiffs are foreign entities;316 when the U.S. 
government has successfully concluded criminal actions against the de-
fendants; and when U.S. plaintiffs have separately pursued, or are pursu-
ing, their own claims against defendants. If these factors are considered, 
and a court initiates the analysis sua sponte in such circumstances, with 
appropriate conditions regarding defendants’ acceptance of foreign juris-
diction, the courts will have achieved the policy goals of the Supreme 
Court’s Empagran decision.317 
It should be mentioned that the federal courts are split over whether, 
and under what circumstances, a district court may dismiss an antitrust 
case, specifically, on forum non conveniens grounds.318 Clearly there is 
                                                                                                             
that the court could raise forum non conveniens sua sponte in response to public interests, 
such as judicial efficiency, based on a reading of Gulf Oil Corp. v. Gilbert, 330 U.S. 501 
(1947). Hannah L. Buxbaum, Forum Selection in International Contract Litigation: The 
Role of Judicial Discretion, 12 WILLAMETTE J. INT’L L. & DISP. RESOL. 185, 198 (2004). 
 316. As a measure of how much litigation in this area has changed, virtually all case 
law and commentary on this subject assumes that at least one party—plaintiff or defen-
dant—is domestic. See generally, e.g., Sandage, supra note 75; Kresic, supra note 293; 
Reynolds, supra note 292; Nijenhuis, supra note 299. 
 317. See Stephen B. Burbank, Jurisdictional Conflict and Jurisdictional Equilibration: 
Paths to a Via Media? 26 HOUS. J. INT’L L. 385, 399 (2004), observing that “it should be 
an acknowledged purpose of forum non conveniens doctrine to achieve the balance that is 
lacking in American law . . . . That, in fact, is what many courts are doing today, when, 
although they speak of convenience and inconvenience, their eyes seem fixed on the 
presence or absence of a domestic regulatory interest.” See also Bates, supra note 46, at 
314–15 (pointing out that forum non conveniens asks a court to dismiss a case over 
which it has already concluded it has subject matter jurisdiction, personal jurisdiction, 
and that venue is proper, and arguing that this sequence of analysis makes forum non 
conveniens a poor means by which to limit the extraterritoriality of U.S. law). 
 318. See generally Lonny Sheinkopf Hoffman & Keith A. Reilly, Forum Non Conven-
iens in Federal Statutory Cases, 49 EMORY L.J. 1137 (2000), for a detailed analysis of the 
circuit split and statutory authority involved in this issue, and noting that Capital Cur-
rency Exch., N.V. v. Nat’l Westminster Bank PLC, 155 F.3d 603, 609 (2d Cir. 1998) held 
that an antitrust suit is subject to dismissal under the forum non conveniens doctrine. Id. 
at 1173–74. The authors argue that, absent a clear statement of congressional intent to 
abrogate the doctrine, the better rule is to presume that courts have the discretion to de-
cline jurisdiction. They propose a rule that the court should exercise it first to ensure that 
the forum with the most significant interest in the dispute adjudicates it; only secondarily 
when it would be seriously inconvenient for the suit to proceed in the forum court. See 
also Reynolds, supra note 292, at 1703 (arguing that the correct approach would be to 
ensure that the federal right is adequately protected in the foreign forum); Sandage, supra 
note 75, at 1713 (countering arguments that Congress has determined that U.S. antitrust 
law should extend to cases that courts would dismiss on forum non conveniens grounds; 
he points out that “it is simply inherent in the doctrine of forum non conveniens that 
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authority for the proposition that courts may do so,319 although it may be 
necessary for the Supreme Court to resolve the split.320 
It is also curious that little has been written about choice of law in the 
context of this issue. It is apparently assumed that once subject matter 
jurisdiction is established, the relevant law to be applied is the lex fori, or 
U.S. law.321 If a court did a choice of law analysis that found a foreign 
antitrust law to be applicable, at least some of the advantages that plain-
tiffs have in bringing suit in U.S. courts would be undermined (although 
discovery, damages, and other procedural issues would be governed by 
the lex fori). 
VIII. CONCLUSION 
This Note argues that the Supreme Court’s Empagran decision pro-
vides little guidance to courts or parties on the extraterritorial effect of 
U.S. antitrust law when foreign plaintiffs sue foreign defendants for inju-
ries sustained outside the United States, with further circuit splits bound 
to develop due to the narrowness of its holding. Absent revision of the 
FTAIA, other legal doctrines, including the test for antitrust standing and 
the doctrine of forum non conveniens, could be used to address the issue. 
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courts will exhaust adjudicative jurisdiction and dismiss a case even where legislative 
jurisdiction would go further . . . [otherwise] the convenient forum doctrine would be 
meaningless . . .”). 
 319. 2 WALLER, ANTITRUST ABROAD, supra note 231, § 21:27. 
 320. Howe v. Goldcorp Investments, Ltd., 946 F.2d 944 (1st Cir. 1991) may be instruc-
tive; Justice Breyer, then Chief Judge of the First Circuit Court of Appeals, who wrote 
the opinion in Empagran, endorsed using forum non conveniens in a federal statutory 
case (with regard to securities regulation). In discussing domestic cases, he said that the 
statute at issue, § 1404(a), “at the least reflects a congressional policy strongly favoring 
transfers . . . . We can find no good policy reason for reading the special venue provisions 
as if someone in Congress really intended them to remove the courts’ legal power to in-
voke the doctrine of forum non conveniens in an otherwise appropriate case.” Id. at 949–
50. Although then-Judge Breyer distinguished antitrust cases from securities cases, his 
comments about the growth in international commerce and the need to use forum non 
conveniens to “help the world’s legal systems work together, in harmony,” id. at 950, 
prefigure his concerns in Empagran. 
 321. 1 WALLER, ANTITRUST ABROAD, supra note 231, § 6:17. 
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